GLP-1 Market
LLY $1288.30 ▲ +0.5% NVO $38.29 ▼ -1.0% PFE $29.45 ▼ -1.2% VKTX $25.36 ▲ +1.9% KLRA $13.42 ▲ +2.2% GPCR $21.48 ▼ -0.3% RHHBY $60.22 ▼ -0.2%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

18F-FDG

Company
NYU Langone Health
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
100 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

100 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 29, 2026

Find a Clinical Trial Near Me

See recruiting studies for 18F-FDG and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02685969

    Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants

    Barcelonabeta Brain Research Center, Pasqual Maragall Foundation 570 participants Est. completion 2027-12-31 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Recruiting NCT NCT03019757

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

    Douglas Scharre 76 participants Est. completion 2027-12-31 1 site
    Other conditions: Alzheimer's Disease, Lewy Body Dementia, Parkinson's Disease
    View official trial listing →
  • Recruiting NCT NCT03604315

    Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

    Not yet reported M.D. Anderson Cancer Center 300 participants Est. completion 2027-06-30 1 site
    Other conditions: Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Solid Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04281641

    Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer

    Not yet reported Fudan University 94 participants Est. completion 2030-04-30 1 site
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04569591

    DDAVP for Pituitary Adenoma

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 22 participants Est. completion 2028-02-26 1 site
    Other conditions: Cushing's Disease, Pituitary Adenoma
    View official trial listing →
  • Recruiting NCT NCT04724928

    Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer

    Not yet reported University Hospital, Ghent 156 participants Est. completion 2030-05 1 site Stand-alone
    Other conditions: Muscle-Invasive Bladder Carcinoma
    View official trial listing →
  • Recruiting NCT NCT04813705

    18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

    Not yet reported Taizhou Hospital 93 participants Est. completion 2029-06-30 4 sites
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT04938362

    Cognitive Function and Fatigue After Brain Abscess

    University of Oslo 50 participants Est. completion 2030-12-31 1 site
    Other conditions: Brain Abscess, Fatigue, Cognitive Dysfunction
    View official trial listing →
  • Recruiting NCT NCT05121779

    Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT

    Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Pulmonary Fibrosis
    View official trial listing →
  • Recruiting NCT NCT05140746

    Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer

    Not yet reported Ruijin Hospital 40 participants Est. completion 2027-09-10 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT05192655

    Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma Patients

    Charite University, Berlin, Germany 250 participants Est. completion 2026-12-01 1 site
    Other conditions: HNSCC
    View official trial listing →
  • Recruiting NCT NCT05255926

    CXCR4-targeted PET/CT Imaging in Hematological Malignancies

    Not yet reported Zhongnan Hospital 300 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: CXCR4, PET/CT, Hematological Malignancy
    View official trial listing →
  • Recruiting NCT NCT05308888

    Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort

    Not yet reported University Hospital, Brest 100 participants Est. completion 2028-11-23 1 site Stand-alone
    Other conditions: Aortic Valve Stenosis
    View official trial listing →
  • Recruiting NCT NCT05321316

    Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma

    Not yet reported Peking University Cancer Hospital & Institute 20 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Urothelial Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05387603

    Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.

    Not yet reported Lund University Hospital 300 participants Est. completion 2026-10-01 4 sites Stand-alone
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Recruiting NCT NCT05436093

    CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

    Not yet reported Peking University Cancer Hospital & Institute 50 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT05463913

    Lung Nodule Detection Using Ultra-long FOV PET/CT

    Not yet reported University Medical Center Groningen 20 participants Est. completion 2025-06-01 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT05549024

    68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

    Not yet reported Peking Union Medical College Hospital 90 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Breast Cancer, Prostate Cancer, Brain Tumor, PET/CT Imaging
    View official trial listing →
  • Recruiting NCT NCT05553899

    Utility of PET-MRI in Surveillance of Paediatric Brain Tumours

    Not yet reported Sheffield Children's NHS Foundation Trust 5 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Brain Tumor, Pediatric
    View official trial listing →
  • Recruiting NCT NCT05593107

    68Ga-N188 PET/CT Imaging in Malignancy

    Not yet reported Peking University First Hospital 203 participants Est. completion 2025-07-31 1 site Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Recruiting NCT NCT05641753

    Cholesterol Lowering and Residual Risk in Diabetes, Type 1

    Not yet reported NYU Langone Health 125 participants Est. completion 2027-07-31 4 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Recruiting NCT NCT05662540

    PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

    Not yet reported Ruijin Hospital 40 participants Est. completion 2026-10 1 site Stand-alone
    Other conditions: NK/T-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05675410

    A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

    Not yet reported National Cancer Institute (NCI) 1875 participants Est. completion 2031-04-28 419 sites
    Other conditions: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05688592

    Usefulness of PET-CT for Invasive Fungal Infection

    Puerta de Hierro University Hospital 224 participants Est. completion 2024-12-01 14 sites
    Other conditions: Invasive Fungal Infections
    View official trial listing →
  • Recruiting NCT NCT05693363

    Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study

    Not yet reported University Hospital, Ghent 40 participants Est. completion 2025-07-31 1 site Stand-alone
    Other conditions: Lung Neoplasms, PET-CT Specimen Imager
    View official trial listing →
  • Recruiting NCT NCT05730608

    18F-FDG PET/CT Imaging for Breast Cancer

    Not yet reported Vestre Viken Hospital Trust 300 participants Est. completion 2032-12-31 1 site
    Other conditions: Breast Cancer Female, Breast Cancer Recurrent
    View official trial listing →
  • Recruiting NCT NCT05747625

    (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

    Not yet reported Eben Rosenthal 60 participants Est. completion 2030-03-01 1 site
    Other conditions: Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Recruiting NCT NCT05806697

    Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study

    Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 240 participants Est. completion 2030-10-09 1 site
    Other conditions: Alzheimer Disease, Memory Complaint, Memory Disorders
    View official trial listing →
  • Recruiting NCT NCT05835570

    Integrin αvβ6-targeted PET in Malignant Tumors

    Zhongnan Hospital 200 participants Est. completion 2025-12-30 1 site
    Other conditions: Malignant Neoplasm, PET/CT, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic
    View official trial listing →
  • Recruiting NCT NCT05873777

    68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

    Not yet reported The First Affiliated Hospital of Xiamen University 30 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: SSTR2, FAP, Positron-Emission Tomography
    View official trial listing →
  • Recruiting NCT NCT05886036

    Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

    Not yet reported National Cancer Institute (NCI) 70 participants Est. completion 2028-10-31 37 sites
    Other conditions: Nodular Lymphocyte Predominant B-Cell Lymphoma, Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma, Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05916196

    [18F]FES PET/.CT in Uterine Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 30 participants Est. completion 2028-08-01 1 site
    Other conditions: Uterine Cancer
    View official trial listing →
  • Recruiting NCT NCT06014515

    Single-tracer Multiparametric PET Imaging

    Not yet reported University of California, Davis 60 participants Est. completion 2033-08 1 site Stand-alone
    Cardiovascular disease Other conditions: Healthy Subjects
    View official trial listing →
  • Recruiting NCT NCT06059469

    PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.

    Not yet reported Jules Bordet Institute 20 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: TNBC - Triple-Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06082492

    The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients

    Not yet reported Radboud University Medical Center 690 participants Est. completion 2029-06 27 sites
    Other conditions: Stage III Non-small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT06092125

    Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

    Xuanwu Hospital, Beijing 2300 participants Est. completion 2028-10-31 1 site
    Other conditions: Alzheimer Disease, Parkinson Disease, Epilepsy, Malignant Brain Tumor
    View official trial listing →
  • Recruiting NCT NCT06103838

    18F-Fluciclovine PET/CT in Multiple Myeloma

    Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2032-12-06 1 site Stand-alone
    Other conditions: Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM)
    View official trial listing →
  • Recruiting NCT NCT06104085

    99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer

    Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06145633

    Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Fred Hutchinson Cancer Center 15 participants Est. completion 2027-12-30 1 site
    Other conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06171659

    FDG PET/MR Imaging of Peripheral Pain Generators

    University of Wisconsin, Madison 128 participants Est. completion 2028-06 1 site
    Other conditions: Pain, Nociceptive Pain
    View official trial listing →
  • Recruiting NCT NCT06179303

    Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Not yet reported University of Washington 60 participants Est. completion 2028-06-01 3 sites
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable HER2-Negative Breast Carcinoma, Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06189898

    Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study

    Sebastian Zschaeck 48 participants Est. completion 2029-01-31 1 site
    Other conditions: Esophagus Cancer
    View official trial listing →
  • Recruiting NCT NCT06224309

    Preliminary Assessment of [18F]BL40 in PET/CT Scans

    British Columbia Cancer Agency 30 participants Est. completion 2027-09-15 1 site
    Other conditions: Diffuse Large B-cell Lymphoma, Multiple Myeloma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, Waldenström Macroglobulinemia
    View official trial listing →
  • Recruiting NCT NCT06236048

    Energetics and Glutamate in Schizophrenia

    King's College London 75 participants Est. completion 2028-12-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT06297902

    RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3

    Not yet reported Oslo University Hospital 100 participants Est. completion 2030-06 3 sites
    Other conditions: Head and Neck Cancer, Radiotherapy Side Effect
    View official trial listing →
  • Recruiting NCT NCT06335914

    Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

    Not yet reported University Health Network, Toronto 30 participants Est. completion 2029-09-04 1 site
    Other conditions: Advanced Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06383520

    Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Malignant Neoplasm of Liver
    View official trial listing →
  • Recruiting NCT NCT06421142

    FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

    Not yet reported First Affiliated Hospital of Fujian Medical University 80 participants Est. completion 2029-06-01 1 site Stand-alone
    Other conditions: Urinary Bladder Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06429891

    Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization

    Not yet reported Hua Zhu 50 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT06450548

    Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA

    Not yet reported Centre Henri Becquerel 60 participants Est. completion 2028-03-05 1 site Stand-alone
    Other conditions: Prostate Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT06519760

    68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

    Not yet reported Peking University First Hospital 200 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Carbonic Anhydrase IX, PET-CT, Clear Cell Renal Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06565936

    DPA-714 and FDG PET/MRI in Depression

    Not yet reported The First Affiliated Hospital of Dalian Medical University 70 participants Est. completion 2026-12 1 site
    Other conditions: Depression
    View official trial listing →
  • Recruiting NCT NCT06629207

    Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

    Not yet reported Insel Gruppe AG, University Hospital Bern 20 participants Est. completion 2026-08-01 1 site Stand-alone
    Other conditions: Parkinson Disease, REM Sleep Behavior Disorder, Dementia, Lewy Body
    View official trial listing →
  • Recruiting NCT NCT06632860

    A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

    Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: Iodine-resistant Thyroid Cancer, Meningioma, NETs
    View official trial listing →
  • Recruiting NCT NCT06646952

    CD147 Targeting Nanobody Probe for PET Imaging in Solid Tumors

    Hua Zhu 30 participants Est. completion 2026-12 1 site
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT06653452

    Application of PET/MRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal Cancer

    Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2026-12-01 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer (LARC)
    View official trial listing →
  • Recruiting NCT NCT06706921

    18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

    Not yet reported VA Greater Los Angeles Healthcare System 15 participants Est. completion 2027-11-01 1 site
    Other conditions: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Metastatic Prostate Cancer, Male Urogenital Diseases, Prostatic Diseases, Urogenital Diseases, Male, Genital Diseases, Male, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Genital Neoplasms, Male
    View official trial listing →
  • Recruiting NCT NCT06708910

    AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

    Heinrich-Heine University, Duesseldorf 460 participants Est. completion 2031-07 1 site
    Other conditions: HER2 Positive Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06709690

    A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases

    Ruijin Hospital 35 participants Est. completion 2025-12-31 1 site
    Other conditions: Paediatric Patients
    View official trial listing →
  • Recruiting NCT NCT06712862

    A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR

    Shanghai East Hospital 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Recruiting NCT NCT06715020

    Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging

    Not yet reported Peking University Cancer Hospital & Institute 60 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06717113

    A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

    Not yet reported Peking University First Hospital 50 participants Est. completion 2028-12 2 sites
    Other conditions: Multiple Myeloma and Malignant Plasma Cell Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06719856

    MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors

    Peking University Cancer Hospital & Institute 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT06739473

    Total-body Glucose Utilization in Obesity

    Not yet reported Turku University Hospital 60 participants Est. completion 2024-12 1 site
    Other conditions: Obesity and Overweight
    View official trial listing →
  • Recruiting NCT NCT06740240

    68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer

    Not yet reported First Affiliated Hospital of Fujian Medical University 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Tumor
    View official trial listing →
  • Recruiting NCT NCT06769893

    A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging

    Not yet reported Xijing Hospital 60 participants Est. completion 2025-11-07 1 site Stand-alone
    Other conditions: RCC, Renal Cell Cancer
    View official trial listing →
  • Recruiting NCT NCT06774209

    Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors

    Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2025-10-01 1 site Stand-alone
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Recruiting NCT NCT06790264

    Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer

    Not yet reported European Institute of Oncology 92 participants Est. completion 2025-11 1 site
    Other conditions: Breast Cancer Invasive, Node Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06794372

    [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

    Not yet reported John O. Prior 20 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Head and Neck Squamous Cell Carcinoma HNSCC
    View official trial listing →
  • Recruiting NCT NCT06795113

    Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

    Ruijin Hospital 4000 participants Est. completion 2029-12-31 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06815029

    Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

    Not yet reported City of Hope Medical Center 27 participants Est. completion 2030-10-11 1 site
    Other conditions: Recurrent Astrocytoma, IDH-Mutant, Grade 3, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Recurrent Glioblastoma
    View official trial listing →
  • Recruiting NCT NCT06835426

    High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

    Not yet reported Algemeen Ziekenhuis Maria Middelares 150 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Breast Carcinoma, Prostate Cancer Surgery, Thyroid Cancer, Parathyroid Adenomas, Skin Cancer, Genitourinary Cancer, Head and Neck Cancer, Hepatobiliary Cancers, Metabolic Abnormality, Neuro Endocrine Tumours, Brain Tumours, Gastro Intestinal Cancer, Thoracoscopic Surgery
    View official trial listing →
  • Recruiting NCT NCT06843629

    Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2028-06-30 1 site
    Other conditions: Ovarian Cancer, Lung Adenocarcinoma, Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT06914999

    Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

    Not yet reported Emory University 20 participants Est. completion 2027-08-31 1 site
    Other conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Stage III Hypopharyngeal Carcinoma AJCC v8, Stage III Laryngeal Cancer AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVA Hypopharyngeal Carcinoma AJCC v8, Stage IVA Laryngeal Cancer AJCC v8, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVB Hypopharyngeal Carcinoma AJCC v8, Stage IVB Laryngeal Cancer AJCC v8, Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06915454

    High-Resolution PET-CT Imaging for Surgical Margin Visualization

    Not yet reported Vanderbilt-Ingram Cancer Center 50 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Cancer, Solid Malignant Tumors, SCC - Squamous Cell Carcinoma, HNSCC, HNSCC,Larynx, Pharynx and Oral Cavity
    View official trial listing →
  • Recruiting NCT NCT06956391

    Ultralow Dose PET Imaging of 18F-FDG Uptake

    Not yet reported Akiva Mintz 200 participants Est. completion 2030-06-30 1 site Stand-alone
    Other conditions: Healthy Volunteer, Cancer
    View official trial listing →
  • Recruiting NCT NCT06962163

    Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients

    Not yet reported Institut Cancerologie de l'Ouest 12 participants Est. completion 2030-06 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06984861

    A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 74 participants Est. completion 2028-05 7 sites
    Other conditions: Oropharyngeal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07046455

    Trop-2 Targeted PET Probes in Advanced TNBC

    Not yet reported Peking University Cancer Hospital & Institute 20 participants Est. completion 2027-09-01 1 site Stand-alone
    Other conditions: TNBC - Triple-Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07046702

    68Ga-MY6349 PET/CT in Solid Tumors

    The First Affiliated Hospital of Xiamen University 300 participants Est. completion 2026-12-31 1 site
    Other conditions: Solid Tumor, Trop2, PET/CT
    View official trial listing →
  • Recruiting NCT NCT07067905

    Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

    Not yet reported Chinese PLA General Hospital 15 participants Est. completion 2026-06-01 1 site Stand-alone
    Other conditions: Clear Cell Renal Cell Carcinoma and Glioblastoma
    View official trial listing →
  • Recruiting NCT NCT07089641

    ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

    Not yet reported Jonsson Comprehensive Cancer Center 50 participants Est. completion 2028-07-30 2 sites
    Obstructive sleep apnea Other conditions: Glioblastoma, Glioblastoma, IDH-Wildtype, Recurrent Glioblastoma, IDH-Wildtype, Resectable Glioblastoma
    View official trial listing →
  • Recruiting NCT NCT07104058

    A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD

    Not yet reported Luo Yaping 46 participants Est. completion 2027-12-01 1 site
    Other conditions: IgG4-Related Diseases
    View official trial listing →
  • Recruiting NCT NCT07144085

    Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.

    Not yet reported Yi Tian 30 participants Est. completion 2027-07-30 1 site Stand-alone
    Other conditions: Tumor, Metastatic Cancer
    View official trial listing →
  • Recruiting NCT NCT07147309

    Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

    Weibing Miao, PhD 60 participants Est. completion 2029-09-01 1 site
    Other conditions: Epilepsy, PET / MR, Synaptic Vesicle Proteins, Microglial Activation, FDG PET
    View official trial listing →
  • Recruiting NCT NCT07215182

    [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

    Not yet reported Barbara Malene Fischer 20 participants Est. completion 2027-02-20 2 sites
    Other conditions: Malignant Melanoma Stage IV
    View official trial listing →
  • Recruiting NCT NCT07278856

    Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

    Not yet reported City of Hope Medical Center 20 participants Est. completion 2027-03-31 1 site
    Other conditions: Follicular Helper T-Cell Lymphoma, Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, Follicular Helper T-Cell Lymphoma, Follicular-Type, Follicular Helper T-Cell Lymphoma, Not Otherwise Specified, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified
    View official trial listing →
  • Recruiting NCT NCT07285564

    Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer

    Not yet reported Centre Henri Becquerel 10 participants Est. completion 2026-06-15 1 site
    Other conditions: Head & Neck Cancer
    View official trial listing →
  • Recruiting NCT NCT07301827

    Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 66 participants Est. completion 2026-05-31 1 site
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07448727

    Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT

    University of Rome Tor Vergata 25 participants Est. completion 2027-12 1 site
    Other conditions: Head & Neck Cancer, Head & Neck Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07471776

    Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer

    Not yet reported Fudan University 45 participants Est. completion 2029-03-11 2 sites
    Other conditions: Metastatic Breast Cancer ( HER2 Negative)
    View official trial listing →
  • Recruiting NCT NCT07482072

    Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study

    Copenhagen University Hospital, Rigshospitalet 60 participants Est. completion 2026-12 1 site
    Other conditions: Alzheimer Dementia (AD), Diabete Type 2
    View official trial listing →
  • Recruiting NCT NCT07494162

    Imaging Metabolic and Perfusion Changes in Acupuncture Therapy for Myofascial Pain Syndrome

    Not yet reported University of California, Davis 64 participants Est. completion 2030-04 1 site
    Other conditions: Myofascial Pain Syndrome (MPS), Chronic Low-back Pain (cLBP)
    View official trial listing →
  • Recruiting NCT NCT07535554

    The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.

    Not yet reported, Not yet reported Universitaire Ziekenhuizen KU Leuven 140 participants Est. completion 2030-03-31 1 site
    Other conditions: Fever of Unknown Origin, IgG4 Related Disease, Axial Spondylarthritis (axSpA), Inflammation of Unknown Origin
    View official trial listing →
  • Recruiting NCT NCT07569887

    Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical Treatment

    Not yet reported University Hospital, Montpellier 10 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Unruptured Brain Arteriovenous Malformation
    View official trial listing →
  • Recruiting NCT NCT07587086

    Fluorocholine PET/MR in Breast Cancer

    Taipei Veterans General Hospital, Taiwan 195 participants Est. completion 2028-07-31 1 site
    Other conditions: Breast Neoplasms, Female
    View official trial listing →
  • Recruiting NCT NCT07670949

    Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies

    Not yet reported Zhejiang Cancer Hospital 30 participants Est. completion 2029-06-01 1 site Stand-alone
    Other conditions: Hematological Malignancies B
    View official trial listing →
  • Recruiting NCT NCT07750470

    Diagnostic Accuracy of 18F-FDG PET/CT in Muscle-invasive Bladder Cancer

    University Hospital of Ferrara 60 participants Est. completion 2026-12 1 site
    Other conditions: Muscle-invasive Bladder Cancer
    View official trial listing →
  • Recruiting NCT NCT07760012

    68Ga-SorB PET/CT Imaging in Patients With Solid Tumors

    Not yet reported Peking University Third Hospital 50 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer, Cholangiocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07847346

    China Aortic Infection and Graft Infection Study: An Ambispective Cohort

    Shanghai Zhongshan Hospital 2000 participants Est. completion 2041-11-01 1 site
    Other conditions: Vascular Graft Infection, Infectious Aortitis, Aortoenteric Fistula
    View official trial listing →
  • Completed NCT NCT00001849

    New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 95 participants Est. completion 2019-04-26 1 site
    Other conditions: Cushing Syndrome, Endocrine Disease
    View official trial listing →
  • Completed NCT NCT00002981

    PET Scan in Treating Patients With Metastatic Prostate Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 173 participants Est. completion 2023-06-12 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00039286

    Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 118 participants Est. completion 2009-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00070239

    Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies

    Not yet reported National Cancer Institute (NCI) 100 participants 1 site
    Other conditions: Hematopoietic/Lymphoid Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00081094

    Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer

    Not yet reported Washington University School of Medicine 31 participants Est. completion 2005-09 1 site
    Other conditions: Liver Cancer
    View official trial listing →
  • Terminated NCT NCT00110032

    Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors

    Not yet reported National Cancer Institute (NCI) 46 participants 1 site
    Obstructive sleep apnea Other conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, Adult Brain Stem Glioma, Adult Central Nervous System Germ Cell Tumor, Adult Choroid Plexus Tumor, Adult Craniopharyngioma, Adult Diffuse Astrocytoma, Adult Ependymoblastoma, Adult Ependymoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Grade I Meningioma, Adult Grade II Meningioma, Adult Grade III Meningioma, Adult Medulloblastoma, Adult Meningeal Hemangiopericytoma, Adult Mixed Glioma, Adult Myxopapillary Ependymoma, Adult Oligodendroglioma, Adult Pilocytic Astrocytoma, Adult Pineoblastoma, Adult Pineocytoma, Adult Subependymoma, Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Meningeal Melanocytoma
    View official trial listing →
  • Completed NCT NCT00123747

    Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer

    Not yet reported AHS Cancer Control Alberta 23 participants Est. completion 2008-10 1 site
    Other conditions: Lung Neoplasms
    View official trial listing →
  • Completed NCT NCT00123760

    Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

    Not yet reported, Not yet reported AHS Cancer Control Alberta 10838 participants Est. completion 2008-12 1 site
    Other conditions: Brain Neoplasms, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Lymphoma
    View official trial listing →
  • Completed NCT NCT00135161

    Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer

    Not yet reported University Hospital, Ghent 40 participants Est. completion 2015-08 1 site
    Other conditions: Head and Neck Neoplasms
    View official trial listing →
  • Completed NCT NCT00172419

    The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.

    Not yet reported National Taiwan University Hospital 43 participants Est. completion 2008-12 1 site
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00193752

    Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix

    Tata Memorial Hospital 100 participants Est. completion 2018-01 1 site
    Other conditions: Cancer of Cervix
    View official trial listing →
  • Completed NCT NCT00207298

    18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

    British Columbia Cancer Agency 39242 participants Est. completion 2015-08 1 site
    Other conditions: Brain Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00238368

    Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59 participants Est. completion 2007-09-17 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00274924

    Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma

    Not yet reported Eastern Cooperative Oncology Group 100 participants Est. completion 2019-03 104 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00286832

    Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV

    Copenhagen University Hospital at Herlev 100 participants Est. completion 2011-01 1 site
    Other conditions: Diffuse Large-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00324467

    Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment

    Not yet reported British Columbia Cancer Agency 150 participants Est. completion 2021-12 1 site
    Other conditions: Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00369980

    Diagnostic Usefulness of Fluorine-18-α-Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient

    Gunma University Est. completion 2005-08 1 site
    Other conditions: Sarcoidosis
    View official trial listing →
  • Completed NCT NCT00406289

    Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor

    Not yet reported University Hospital, Ghent 24 participants Est. completion 2010-02 1 site
    Other conditions: Head and Neck Tumor
    View official trial listing →
  • Completed NCT NCT00497614

    Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)

    Not yet reported University Hospital, Tours 8 participants Est. completion 2008-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00522639

    Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation

    Not yet reported Maastricht Radiation Oncology 120 participants Est. completion 2009-06 1 site
    Other conditions: Lung Cancer, SCLC, NSCLC
    View official trial listing →
  • Terminated NCT NCT00528294

    Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area

    Not yet reported University Hospital, Ghent 12 participants Est. completion 2015-09 1 site
    Other conditions: Head and Neck Tumors
    View official trial listing →
  • Completed NCT NCT00537056

    Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI

    Not yet reported Stanford University 17 participants Est. completion 2012-04 1 site
    Other conditions: Kidney Neoplasms, Carcinoma, Renal Cell, Kidney (Renal Cell) Cancer
    View official trial listing →
  • Completed NCT NCT00537797

    Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules

    Not yet reported Washington University School of Medicine 84 participants Est. completion 2014-02 3 sites
    Other conditions: Thyroid Neoplasms
    View official trial listing →
  • Completed NCT NCT00559377

    FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer

    Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2014-05 1 site
    Other conditions: Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer
    View official trial listing →
  • Completed NCT NCT00590395

    FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis

    Not yet reported Alan D. Waxman, M.D. 19 participants Est. completion 2010-07 1 site
    Other conditions: Cholecystitis
    View official trial listing →
  • Completed NCT NCT00606294

    Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

    Not yet reported Memorial Sloan Kettering Cancer Center 216 participants Est. completion 2023-06-09 5 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00620243

    Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.

    Not yet reported Memorial Sloan Kettering Cancer Center 9 participants Est. completion 2008-11 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00695305

    An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks

    Not yet reported GlaxoSmithKline 83 participants Est. completion 2010-05 10 sites
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00698373

    Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study

    Gunma University
    Other conditions: Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00757549

    3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

    Not yet reported Mayo Clinic 30 participants Est. completion 2017-10-25 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Status unknown NCT NCT00765986

    Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

    AHS Cancer Control Alberta 30 participants Est. completion 2015-10 1 site
    Other conditions: Lung Neoplasm, Cell Hypoxia
    View official trial listing →
  • Completed NCT NCT00770731

    Study of Temsirolimus, Topotecan, and Bortezomib

    Not yet reported M.D. Anderson Cancer Center 80 participants Est. completion 2012-11 1 site
    Other conditions: Advanced Cancer
    View official trial listing →
  • Terminated NCT NCT00771381

    A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer

    Not yet reported AHS Cancer Control Alberta 23 participants Est. completion 2019-02-04 1 site
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT00788489

    A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy

    Ontario Clinical Oncology Group (OCOG) 49 participants Est. completion 2010-04 1 site
    Other conditions: Locally Advanced Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00809341

    R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27 participants Est. completion 2014-04 1 site
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Terminated NCT NCT00811122

    Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly

    Not yet reported University of Utah 2 participants Est. completion 2021-12 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00816335

    Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

    Not yet reported Ohio State University Comprehensive Cancer Center 65 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00816582

    PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

    Not yet reported British Columbia Cancer Agency 17 participants Est. completion 2018-07 4 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00823810

    Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT

    Not yet reported Turku University Hospital 20 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00833209

    Orbitofrontal Cortex (OFC) Influence on Addictive Medication Overuse Headache (MOH) Deriving From Migraine

    Not yet reported University Hospital, Bordeaux 53 participants Est. completion 2012-05 2 sites
    Other conditions: Medication Overuse Headache
    View official trial listing →
  • Completed NCT NCT00864110

    Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

    Not yet reported Cell>Point LLC 4 participants Est. completion 2010-12 3 sites
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00865319

    Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

    Not yet reported Cell>Point LLC 22 participants Est. completion 2010-12 6 sites
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00887718

    Positron Emission Tomography(PET) in Lymphoma Assessment

    Not yet reported University Health Network, Toronto 103 participants Est. completion 2011-06 1 site
    Other conditions: Hodgkin's Lymphoma, Non Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00906503

    Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules

    Not yet reported Barbara Ann Karmanos Cancer Institute 9 participants Est. completion 2012-04 2 sites Stand-alone
    Other conditions: Pulmonary Nodule
    View official trial listing →
  • Completed NCT NCT00958087

    Cardiac Sarcoidosis and FDG-PET

    Kurume University 20 participants Est. completion 2010-07 1 site
    Other conditions: Sarcoidosis, Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT00959582

    Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)

    Not yet reported Merck Sharp & Dohme LLC 42 participants Est. completion 2011-10
    Other conditions: Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
    View official trial listing →
  • Terminated NCT NCT01022138

    Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer

    Not yet reported Barbara Ann Karmanos Cancer Institute 43 participants Est. completion 2019-02-19 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01031238

    Comparison of PEM Uptake Value (PUV) and Standardized Uptake Value (SUV) in Patients With Malignancies of the Breast

    M.D. Anderson Cancer Center 5 participants Est. completion 2015-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01038778

    Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 47 participants Est. completion 2027-02-12 4 sites
    Other conditions: Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT01099865

    High-sensitivity C-reactive Protein and United Kingdom Prospective Diabetes Study (UKPDS) Risk Score in Type 2 Diabetes

    Korea University 56 participants Est. completion 2010-04 1 site
    Type 2 diabetes Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01103726

    Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects

    Not yet reported Pfizer 34 participants Est. completion 2011-11 3 sites
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT01117155

    A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas

    National Cancer Institute (NCI) Est. completion 2012-10-22
    Other conditions: Ependymoma, Brainstem Glioma, Astrocytoma, Glioblastoma Multiforme, PNET
    View official trial listing →
  • Completed NCT NCT01136720

    Clinical Trial to Evaluate the Safety and Clinical Utility of 18F-FDG Produced by the Molecular Imaging and Research Centre of Nova Scotia

    Nova Scotia Health Authority 9463 participants Est. completion 2017-04-18 1 site
    Other conditions: 18FDG
    View official trial listing →
  • Completed NCT NCT01139827

    Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography

    Korea University Guro Hospital 178 participants Est. completion 2010-02 1 site
    Other conditions: Cardiovascular Risk
    View official trial listing →
  • Terminated NCT NCT01141764

    Cerebral Metabolic Changes Associated With Thalamic Stimulation

    Not yet reported The Hospital for Sick Children 4 participants Est. completion 2014-02 2 sites Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT01146054

    Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma

    Not yet reported Stanford University 59 participants Est. completion 2015-10 3 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01150006

    Correlation Between Various Adipokines and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG) (18FDG-PET)

    Korea University 90 participants Est. completion 2010-06 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01150019

    Correlation Between Circulating Resistin and Vascular Inflammation Measured by 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) (18FDG-PET)

    Korea University 120 participants Est. completion 2010-06 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT01169350

    18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma

    Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2013-08 2 sites
    Other conditions: Recurrent Adult Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    View official trial listing →
  • Status unknown NCT NCT01171300

    Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients

    Not yet reported Universitaire Ziekenhuizen KU Leuven 94 participants Est. completion 2025-12 1 site
    Other conditions: Adenocarcinoma, Rectal Neoplasms
    View official trial listing →
  • Completed NCT NCT01179360

    Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

    University Hospital, Antwerp 152 participants Est. completion 2015-12 3 sites
    Other conditions: Locally Advanced Squamous Cell Carcinoma of the Head and Neck Region
    View official trial listing →
  • Completed NCT NCT01202994

    Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET

    Not yet reported University of Utah 27 participants Est. completion 2020-10-14 1 site Stand-alone
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT01218191

    Acute Neurocardiogenic Injury After Subarachnoid Hemorrhage.

    Direction Centrale du Service de Santé des Armées 30 participants Est. completion 2012-02 1 site
    Other conditions: Subarachnoid Hemorrhage
    View official trial listing →
  • Terminated NCT NCT01222416

    PET/CT Evaluation of Treatment Response in Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 50 participants Est. completion 2015-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01253252

    Endoprosthesis Treatment Effects on Human Abdominal Aorta Aneurysms (AAA) Metabolic Activity

    Not yet reported Central Hospital, Nancy, France 45 participants 7 sites
    Other conditions: Abdominal Aortic Aneurysm
    View official trial listing →
  • Completed NCT NCT01266954

    An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer

    Not yet reported GlaxoSmithKline 36 participants Est. completion 2011-09-01 1 site
    Other conditions: Solid Tumours
    View official trial listing →
  • Terminated NCT NCT01283178

    Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

    Not yet reported Virginia Commonwealth University 3 participants Est. completion 2016-09 1 site
    Other conditions: Salivary Gland Squamous Cell Carcinoma, Stage II Salivary Gland Cancer, Stage II Squamous Cell Carcinoma of the Hypopharynx, Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage II Squamous Cell Carcinoma of the Oropharynx, Stage II Verrucous Carcinoma of the Oral Cavity, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Verrucous Carcinoma of the Oral Cavity
    View official trial listing →
  • Completed NCT NCT01284829

    Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study

    Not yet reported Assistance Publique Hopitaux De Marseille 87 participants Est. completion 2023-04-05 1 site
    Other conditions: Adrenal Tumors
    View official trial listing →
  • Completed NCT NCT01285765

    Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients

    Not yet reported The Lymphoma Academic Research Organisation 650 participants Est. completion 2020-05-23 83 sites
    Other conditions: DLBCL
    View official trial listing →
  • Completed NCT NCT01325259

    FluoroAv45 Imaging Research-in Alzheimer's Disease

    Not yet reported University Hospital, Tours 54 participants Est. completion 2013-12 4 sites
    Other conditions: Alzheimer's Disease, Mild Cognitive Impairment
    View official trial listing →
  • Status unknown NCT NCT01330186

    Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy

    Copenhagen University Hospital at Herlev 50 participants Est. completion 2012-05 1 site
    Other conditions: Anal Cancer
    View official trial listing →
  • Completed NCT NCT01347281

    PET With [18F]HX4 in Head and Neck Cancer

    Not yet reported Maastricht Radiation Oncology 23 participants Est. completion 2015-09 1 site
    Other conditions: Cancer of the Head and Neck
    View official trial listing →
  • Status unknown NCT NCT01357733

    Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients

    Not yet reported The Catholic University of Korea 53 participants Est. completion 2023-03-31 1 site
    Other conditions: Lymphoma, Large B-Cell, Diffuse
    View official trial listing →
  • Not yet recruiting NCT NCT01394679

    A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer

    Not yet reported Cell>Point LLC 154 participants Est. completion 2026-12 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT01407796

    PET Imaging of Endotoxin-induced iNOS Activation

    Not yet reported Washington University School of Medicine 19 participants Est. completion 2012-04 1 site
    Other conditions: Pneumonia
    View official trial listing →
  • Completed NCT NCT01421953

    Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers

    Not yet reported University Hospital, Bordeaux 7 participants Est. completion 2012-11 1 site
    Other conditions: Lung Cancer, Non-small-cell Lung Carcinoma
    View official trial listing →
  • Completed NCT NCT01427010

    A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.

    Not yet reported University Hospital, Ghent 10 participants Est. completion 2015-08 2 sites
    Other conditions: Re-irradiation in Recurrent and Second Primary Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT01467219

    Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer

    Not yet reported University Health Network, Toronto 12 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Withdrawn NCT NCT01471418

    The Use of PET/CT to Evaluate Synovitis in the Temporomandibular Joint (TMJ)

    Not yet reported University of Pennsylvania Est. completion 2012-10 1 site
    Other conditions: Temporomandibular Joint, Conservative Treatment Therapy
    View official trial listing →
  • Completed NCT NCT01482182

    Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy

    Samsung Medical Center 35 participants Est. completion 2014-01 1 site
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01486342

    PET Imaging in Patients at Risk for Acute Lung Injury

    Washington University School of Medicine 5 participants Est. completion 2012-10 1 site
    Other conditions: Acute Lung Injury, Early Pulmonary Neutrophilic Inflammation
    View official trial listing →
  • Status unknown NCT NCT01510990

    First Line Gefitinib by FDG-PET Metabolic Response

    Not yet reported Asan Medical Center 60 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Terminated NCT NCT01520025

    Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA

    Not yet reported Ottawa Heart Institute Research Corporation 18 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Myocardial Ischemia
    View official trial listing →
  • Suspended NCT NCT01542853

    The Value of PET/CT in Diagnosing Residual Disease in Patients With Spinal Infection

    Odense University Hospital 10 participants Est. completion 2013-03 3 sites
    Other conditions: Spondylodiscitis
    View official trial listing →
  • Status unknown NCT NCT01553513

    PET/CT for the Quantification of Atherosclerotic Plaque Inflammation

    Ludwig-Maximilians - University of Munich 140 participants Est. completion 2014-12 1 site
    Cardiovascular disease Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01612936

    T Cell Effector and Regulatory Mechanisms in Asthma

    Not yet reported Andrew D. Luster, M.D.,Ph.D. 168 participants Est. completion 2016-09 1 site
    Other conditions: Asthma, Allergies
    View official trial listing →
  • Completed NCT NCT01613196

    Positron Emission Tomography in Extrapulmonary Tuberculosis

    Not yet reported Assistance Publique - Hôpitaux de Paris 55 participants Est. completion 2018-03 1 site
    Other conditions: Extrapulmonary Tuberculosis, Lymph Node Tuberculosis, Bone Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT01636674

    18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer

    Not yet reported Naestved Hospital 66 participants Est. completion 2013-03
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT01655745

    Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer

    Not yet reported UNC Lineberger Comprehensive Cancer Center 22 participants Est. completion 2019-02-01 1 site
    Other conditions: Bladder Cancer
    View official trial listing →
  • Completed NCT NCT01663753

    Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy

    Not yet reported Hospices Civils de Lyon 146 participants Est. completion 2018-08 24 sites Stand-alone
    Other conditions: Cancer of the Uterine Cervix
    View official trial listing →
  • Completed NCT NCT01665703

    Imaging Correlates of Renal Cell Carcinoma Biological Features

    Not yet reported UNC Lineberger Comprehensive Cancer Center 17 participants Est. completion 2019-01 1 site
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01666353

    PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20 participants Est. completion 2018-12-04 1 site
    Other conditions: Melanoma, Renal Cell Carcinoma (RCC), Non-small Cell Lung Cancer (NSCLC)
    View official trial listing →
  • Completed NCT NCT01691391

    Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.

    Amsterdam UMC, location VUmc 46 participants Est. completion 2020-11-03 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01724749

    Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT

    Odense University Hospital 144 participants Est. completion 2016-12 2 sites
    Cardiovascular disease Other conditions: Atherosclerosis, Angina Pectoris
    View official trial listing →
  • Completed NCT NCT01749254

    Novel Imaging Approaches To Identify Unstable Coronary Plaques

    University of Edinburgh 80 participants Est. completion 2015-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Approved For Marketing NCT NCT01764191

    18F-FDG PET Imaging in Cardiac Sarcoidosis

    British Columbia Cancer Agency 1 site
    Other conditions: Cardiac Sarcoidosis
    View official trial listing →
  • Status unknown NCT NCT01783002

    11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues

    Not yet reported University of British Columbia 50 participants Est. completion 2018-07 1 site Stand-alone
    Other conditions: Primary Hyperparathyroidism
    View official trial listing →
  • Completed NCT NCT01800032

    PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)

    UNC Lineberger Comprehensive Cancer Center 30 participants Est. completion 2019-12-05 1 site
    Other conditions: Neurofibromatosis-1, Optic Glioma, Plexiform Neurofibroma
    View official trial listing →
  • Completed NCT NCT01812031

    Benefits Study of Respiratory-gated PET Acquisition in Lung Disease

    Not yet reported Centre Hospitalier Universitaire, Amiens 103 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Lung Cancer, Non Small Cell Lung Cancer, Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Terminated NCT NCT01815112

    Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging

    Not yet reported Centre Hospitalier Universitaire, Amiens 60 participants Est. completion 2014-04 2 sites
    Other conditions: Alzheimer Disease, Mild Cognitive Impairment, Vascular Dementia
    View official trial listing →
  • Completed NCT NCT01916057

    Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis

    Not yet reported Assistance Publique - Hôpitaux de Paris 100 participants Est. completion 2018-02-28 1 site Stand-alone
    Other conditions: Invasive Fungal Disease, Chronic Disseminated Candidiasis, Hematological Malignancies, Hematopoietic Stem Cell Transplantation, Neutropenia
    View official trial listing →
  • Completed NCT NCT01917136

    11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension

    Not yet reported University of Pennsylvania 21 participants Est. completion 2018-10 1 site Stand-alone
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Status unknown NCT NCT01927939

    18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.

    National Taiwan University Hospital 100 participants Est. completion 2014-08 1 site
    Other conditions: Breast Cancer, 18F-FDG PET
    View official trial listing →
  • Status unknown NCT NCT01940926

    68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis

    Not yet reported Peking Union Medical College Hospital 50 participants Est. completion 2017-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01958411

    Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)

    Korea University 340 participants 1 site
    Other conditions: Atherosclerosis, Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Terminated NCT NCT01984905

    Study of Prognostic Factors in Aortic Dissection Type B

    University Hospital, Caen 100 participants Est. completion 2018-05-15 1 site
    Other conditions: Type B Aortic Dissection
    View official trial listing →
  • Completed NCT NCT01996046

    FDG PET/CT in Breast Cancer Bone Mets

    University of Pennsylvania 26 participants Est. completion 2026-07-31 1 site
    Other conditions: Estrogen Receptor Positive Breast Cancer, Bone Metastases
    View official trial listing →
  • Completed NCT NCT02003456

    Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging

    Not yet reported University of Michigan 30 participants Est. completion 2014-08 1 site
    Cardiovascular disease Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Terminated NCT NCT02010957

    Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia

    Not yet reported Wuerzburg University Hospital 85 participants Est. completion 2022-07 6 sites
    Other conditions: Adrenal Neoplasia
    View official trial listing →
  • Completed NCT NCT02039024

    Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PET

    Not yet reported Chang Gung Memorial Hospital 18 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02059733

    Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism

    Not yet reported Chang Gung Memorial Hospital 72 participants Est. completion 2018-07-31 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Withdrawn NCT NCT02061007

    Biomarker Correlates of Hypoxia in Metastatic Melanoma

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2016-02
    Other conditions: Melanoma, Skin Cancer
    View official trial listing →
  • Status unknown NCT NCT02074202

    To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma

    Not yet reported National Taiwan University Hospital 150 participants Est. completion 2015-03 1 site
    Other conditions: Hepatocellular Carcinoma, Liver Disease
    View official trial listing →
  • Completed NCT NCT02078141

    18F-deoxyglucose (FDG) PET-CMD

    Not yet reported Nantes University Hospital 30 participants Est. completion 2018-01-18 2 sites
    Other conditions: Patients With Idiopathic Dilated Cardiomyopathy
    View official trial listing →
  • Terminated NCT NCT02079181

    18F-FMAU PET/CT in Imaging Patients With Advanced Cancers

    Not yet reported University of Southern California 3 participants Est. completion 2023-08-22 1 site
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT02081482

    Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation

    Not yet reported Centre Hospitalier Universitaire de Nice 20 participants Est. completion 2022-02-02 4 sites Stand-alone
    Other conditions: Refractory Chronic Cluster Headache
    View official trial listing →
  • Status unknown NCT NCT02089204

    Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma

    Xuzhou Medical University 300 participants Est. completion 2015-12
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Completed NCT NCT02167256

    A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease

    Not yet reported Yale University 159 participants Est. completion 2018-02-27 22 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02173834

    Brown Adipose Tissue and Body Mass Index

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20 participants Est. completion 2013-11 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02175095

    [18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib

    Not yet reported Asan Medical Center 68 participants Est. completion 2019-04-30 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02180308

    Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI

    NYU Langone Health 23 participants Est. completion 2018-09-11 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT02193425

    Reliability of the Human Brain Connectome

    Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 112 participants Est. completion 2023-05-23 1 site
    Other conditions: Normal Physiology
    View official trial listing →
  • Terminated NCT NCT02204202

    PET Assessment of Acute Lung Transplant Rejection

    Washington University School of Medicine 28 participants Est. completion 2017-02-04 1 site
    Other conditions: Lung Disease
    View official trial listing →
  • Completed NCT NCT02208544

    FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS)

    Not yet reported Radboud University Medical Center 132 participants Est. completion 2022-02-15 15 sites
    Other conditions: Thyroid Nodule, Thyroid Neoplasms
    View official trial listing →
  • Completed NCT NCT02211768

    Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

    Not yet reported National Cancer Institute (NCI) 10 participants Est. completion 2019-12-30 1 site
    Other conditions: Neurofibromatosis, MPNST
    View official trial listing →
  • Completed NCT NCT02237872

    Detection of Brown Adipose Tissue by Magnetic Resonance Imaging

    University of North Carolina, Chapel Hill 8 participants Est. completion 2015-08-27 2 sites
    Other conditions: Obesity, Brown Adipose Tissue
    View official trial listing →
  • Active, not recruiting NCT NCT02285192

    Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 42 participants Est. completion 2026-11 7 sites Stand-alone
    Other conditions: Cervical Cancer, Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT02300402

    Detection and Characterization of Residual Masses in Lymphomas

    The Lymphoma Academic Research Organisation 120 participants Est. completion 2022-12 1 site
    Other conditions: Hodgkin Lymphoma, B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02305264

    Imaging of Intracerebral Inflammation in MS

    Not yet reported Assistance Publique - Hôpitaux de Paris 61 participants Est. completion 2018-09-10 2 sites Stand-alone
    Other conditions: Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive
    View official trial listing →
  • Status unknown NCT NCT02327442

    68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients

    Xijing Hospital 46 participants Est. completion 2015-12 1 site
    Other conditions: Glioma, Breast Cancer
    View official trial listing →
  • Completed NCT NCT02334371

    MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study

    Not yet reported Maastricht University Medical Center 10 participants Est. completion 2016-03 1 site
    Other conditions: Ovarian Neoplasms
    View official trial listing →
  • Terminated NCT NCT02343757

    Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid

    Not yet reported University Hospitals Cleveland Medical Center 4 participants Est. completion 2016-11-09 1 site
    Other conditions: Dementia, Alzheimer Disease
    View official trial listing →
  • Terminated NCT NCT02350426

    A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques

    Not yet reported GlaxoSmithKline 10 participants Est. completion 2016-10-26 2 sites Stand-alone
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT02378337

    Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

    Hospital Sao Rafael 335 participants Est. completion 2016-03 1 site
    Other conditions: Malignant Neoplasm of Breast, Hodgkin Disease, Non-Hodgkin Lymphoma, Follicular (Nodular), Malignant Neoplasm of Bronchus and Lung, Malignant Neoplasm of Colon, Secondary Neoplasm Malignant and Unspecified Lymph Nodes, Malignant Melanoma of the Skin, Malignant Neoplasm of Small Intestine
    View official trial listing →
  • Active, not recruiting NCT NCT02386709

    Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer

    Not yet reported Centre Georges Francois Leclerc 275 participants Est. completion 2028-03-25 1 site
    Other conditions: FDG PET
    View official trial listing →
  • Status unknown NCT NCT02391246

    Radionecrosis and FDG PET

    Ottawa Hospital Research Institute 62 participants Est. completion 2020-03 1 site
    Other conditions: Malignant Glioma
    View official trial listing →
  • Completed NCT NCT02409784

    PET Study of Cerebral Metabolism of 11C-acetoacetate and 18F-FDG in Patients Under Moderate Ketosis

    Not yet reported Université de Sherbrooke 10 participants Est. completion 2015-01
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02448225

    18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

    Not yet reported Vanderbilt-Ingram Cancer Center 46 participants Est. completion 2022-10-10 2 sites Stand-alone
    Other conditions: Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior
    View official trial listing →
  • Status unknown NCT NCT02469129

    PET Imaging of PARP Activity in Cancer

    Not yet reported Washington University School of Medicine 50 participants Est. completion 2025-07 1 site Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT02481726

    68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

    Not yet reported, Not yet reported Xijing Hospital 31 participants Stand-alone
    Other conditions: Lung Cancer, Lung Tuberculosis
    View official trial listing →
  • Completed NCT NCT02515084

    Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma

    Not yet reported Centre Henri Becquerel 37 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Thyroid Cancer, Relapse
    View official trial listing →
  • Completed NCT NCT02528695

    Adipose Tissue Imaging in Type 2 Diabetes

    Not yet reported Radboud University Medical Center 15 participants Est. completion 2017-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02550613

    Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma

    National Taiwan University Hospital 100 participants Est. completion 2018-04 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT02595879

    Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

    Not yet reported National Cancer Institute (NCI) 21 participants Est. completion 2027-04-29 17 sites
    Other conditions: Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma, Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma, Stage IB2 Cervical Cancer AJCC v6 and v7, Stage II Cervical Cancer AJCC v7, Stage II Vaginal Cancer AJCC v6 and v7, Stage III Vaginal Cancer AJCC v6 and v7, Stage IIIB Cervical Cancer AJCC v6 and v7, Stage IVA Cervical Cancer AJCC v6 and v7, Stage IVA Vaginal Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT02601547

    PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma

    Not yet reported University Hospital, Toulouse 18 participants Est. completion 2013-03 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT02607423

    Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

    Not yet reported ECOG-ACRIN Cancer Research Group Est. completion 2017-01-31 1 site Stand-alone
    Other conditions: Stage IIIA Non-Small Cell Lung Cancer
    View official trial listing →
  • Terminated NCT NCT02608528

    Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy

    Abramson Cancer Center at Penn Medicine 10 participants Est. completion 2019-07-18 1 site
    Other conditions: Non-Small Cell Lung Cancer (NSCLC)
    View official trial listing →
  • Status unknown NCT NCT02621541

    Nonfunctional Pancreatic NET and PET Imaging

    Not yet reported Turku University Hospital 20 participants Est. completion 2019-02 2 sites
    Other conditions: Diagnosis
    View official trial listing →
  • Completed NCT NCT02664792

    Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer

    Not yet reported Latin American Cooperative Oncology Group 108 participants Est. completion 2016-12 1 site
    Other conditions: Non-small Cell Lung Carcinoma
    View official trial listing →
  • Completed NCT NCT02678884

    Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study

    Not yet reported University Health Network, Toronto 19 participants Est. completion 2025-01-13 1 site
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT02708485

    Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease

    Not yet reported Université de Sherbrooke 15 participants Est. completion 2017-07 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02717572

    18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

    Not yet reported Washington University School of Medicine 19 participants Est. completion 2017-06-05 1 site
    Other conditions: Solid Tumor, Adult
    View official trial listing →
  • Completed NCT NCT02751710

    Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer

    Not yet reported Ontario Clinical Oncology Group (OCOG) 369 participants Est. completion 2023-03-31 6 sites
    Other conditions: Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4), Stage IIb Breast Cancer (T3N0)
    View official trial listing →
  • Status unknown NCT NCT02759978

    Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL

    University Medical Center Groningen 300 participants Est. completion 2023-05 1 site
    Other conditions: Endocarditis, Prosthetic Material Related Infection
    View official trial listing →
  • Completed NCT NCT02763735

    Right Ventricular Metabolism in Pulmonary Arterial Hypertension

    Vanderbilt University Medical Center 34 participants Est. completion 2019-06 1 site
    Other conditions: Pulmonary Arterial Hypertension, Healthy
    View official trial listing →
  • Status unknown NCT NCT02845570

    Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TB

    Not yet reported National University Hospital, Singapore 8 participants 2 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Terminated NCT NCT02847468

    Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

    Not yet reported Centre Georges Francois Leclerc 61 participants Est. completion 2021-12-23 1 site
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Status unknown NCT NCT02855190

    Comparative Study With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection

    Not yet reported Chang Gung Memorial Hospital 30 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Infection and Inflammatory Reaction Due to Internal Joint Prosthesis
    View official trial listing →
  • Completed NCT NCT02886793

    Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects

    Not yet reported, Not yet reported Joan Albert Barbera Mir 65 participants Est. completion 2018-08
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Terminated NCT NCT02891616

    18F-FLT PET Imaging in Patients With Advanced Melanoma

    Not yet reported Washington University School of Medicine 4 participants Est. completion 2017-12-31 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Withdrawn NCT NCT02899325

    FDGal PET/CT to Detect Hepatocellular Carcinoma

    British Columbia Cancer Agency Est. completion 2021-10 1 site
    Other conditions: Hepatocellular Carcinoma, Liver Cirrhosis, Chronic Liver Disease
    View official trial listing →
  • Status unknown NCT NCT02931201

    Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma

    Not yet reported Peking University Cancer Hospital & Institute 100 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Lymphoma, Large B-Cell, Diffuse
    View official trial listing →
  • Status unknown NCT NCT02938546

    18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study

    Not yet reported Shanghai Chest Hospital 200 participants Est. completion 2023-01 Stand-alone
    Other conditions: Non-small-cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02953197

    18F-FDG-PET Guided Dose-Painting With Intensity Modulated Radiotherapy in Oropharyngeal Tumours

    Not yet reported Guy's and St Thomas' NHS Foundation Trust 26 participants Est. completion 2019-01-31 1 site
    Other conditions: Oropharyngeal Cancer
    View official trial listing →
  • Completed NCT NCT02955966

    PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis

    Not yet reported Assistance Publique - Hôpitaux de Paris 51 participants Est. completion 2022-05-02 1 site Stand-alone
    Other conditions: Aspergillosis and Haematological Malignancy
    View official trial listing →
  • Status unknown NCT NCT02969278

    Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy

    Not yet reported Catholic University of the Sacred Heart 50 participants Est. completion 2017-07 1 site
    Other conditions: Vulvar Cancer
    View official trial listing →
  • Terminated NCT NCT02970851

    Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PET/CT on PAH and CTEPH

    University of Lausanne Hospitals 2 participants Est. completion 2018-12-31 1 site
    Other conditions: Myocardial Dysfunction, Endothelial Dysfunction
    View official trial listing →
  • Status unknown NCT NCT02985424

    Polymyalgia Rheumatica and Giant Cell Arteritis

    Svendborg Hospital 80 participants Est. completion 2020-02 1 site
    Other conditions: Polymyalgia Rheumatica, Giant Cell Arteritis
    View official trial listing →
  • Completed NCT NCT03015818

    Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD)

    Not yet reported Nantes University Hospital 25 participants Est. completion 2019-05-03 1 site Stand-alone
    Other conditions: Aortic Bioprosthesis Structural Valve Dysfunction
    View official trial listing →
  • Status unknown NCT NCT03029793

    Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer

    Air Force Military Medical University, China 200 participants Est. completion 2020-01 1 site
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT03032601

    Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis

    Not yet reported Thomas Jefferson University 55 participants Est. completion 2027-07-08 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Status unknown NCT NCT03033485

    18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis

    Not yet reported Xijing Hospital 50 participants Est. completion 2018-12 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Status unknown NCT NCT03051542

    Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma

    Not yet reported Peking University Cancer Hospital & Institute 60 participants Est. completion 2020-12-31 1 site Stand-alone
    Other conditions: Lymphoma, Extranodal NK-T-Cell
    View official trial listing →
  • Status unknown NCT NCT03051581

    18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma

    Not yet reported Peking University Cancer Hospital & Institute 80 participants Est. completion 2020-12-31 1 site Stand-alone
    Other conditions: Lymphoma, T-Cell, Peripheral
    View official trial listing →
  • Terminated NCT NCT03065790

    Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on Lenalidomide

    Abramson Cancer Center at Penn Medicine 1 participants Est. completion 2021-04-28 1 site
    Other conditions: Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT03089606

    Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker

    Not yet reported UNC Lineberger Comprehensive Cancer Center 27 participants Est. completion 2023-07-01 2 sites
    Other conditions: Melanoma
    View official trial listing →
  • Status unknown NCT NCT03121456

    18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma

    Not yet reported Centre Antoine Lacassagne 74 participants Est. completion 2024-04-12 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT03123289

    Novel Gallium 68 Citrate in Orthopedic Infections

    Not yet reported Rutgers, The State University of New Jersey 1 participants Est. completion 2020-10-14 1 site Stand-alone
    Other conditions: Joint Prosthesis
    View official trial listing →
  • Completed NCT NCT03125629

    Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

    Not yet reported Stanford University 53 participants Est. completion 2020-02-05 1 site Stand-alone
    Other conditions: Cancer Diagnosis, Diagnostic Techniques and Procedures, Diagnostic Imaging
    View official trial listing →
  • Terminated NCT NCT03129776

    Hyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer (LACC) Cervical Cancer

    Not yet reported Sunnybrook Health Sciences Centre 4 participants Est. completion 2022-09-15 1 site
    Other conditions: Uterine Cervical Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT03161353

    Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.

    Not yet reported MedSIR 377 participants Est. completion 2026-11-01 56 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03173924

    18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 96 participants Est. completion 2028-02-06 1 site Stand-alone
    Other conditions: Metastatic Prostate Cancer, Prostatic Neoplasms, Prostate Cancer, Prostatic Cancer, Prostate Neoplasms
    View official trial listing →
  • Completed NCT NCT03188354

    Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

    Not yet reported Norwegian University of Science and Technology 3 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin, Central Nervous System Neoplasms
    View official trial listing →
  • Completed NCT NCT03191643

    PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 16 participants Est. completion 2016-01-31
    Other conditions: Differentiated Thyroid Cancer
    View official trial listing →
  • Completed NCT NCT03195270

    Use of PET/MR Imaging in Chronic Pain

    Not yet reported Stanford University 88 participants Est. completion 2022-01-20 1 site
    Other conditions: Chronic Pain
    View official trial listing →
  • Terminated NCT NCT03231397

    Predictors of AAA Expansion and/or Rupture

    Not yet reported Washington University School of Medicine 2 participants Est. completion 2020-04-30 1 site
    Other conditions: Abdominal Aortic Aneurysm (AAA)
    View official trial listing →
  • Completed NCT NCT03268369

    PET Study of the Nicotinic System in Epilepsy

    Not yet reported Fabienne PICARD 48 participants Est. completion 2015-11
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT03272997

    The Value of PET-CT in Pleural Effusions

    Naestved Hospital 112 participants Est. completion 2019-01-30 1 site
    Other conditions: Pleural Effusion, Malignant
    View official trial listing →
  • Withdrawn NCT NCT03295695

    PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2022-12 1 site
    Other conditions: Breast Cancer, Breast Cancer, Female, Breast Cancer, Male, Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT03352037

    18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study

    Not yet reported University Health Network, Toronto 11 participants Est. completion 2018-07-31 1 site
    Other conditions: Pancreatic Cystic Neoplasms
    View official trial listing →
  • Completed NCT NCT03356470

    Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

    University of Wisconsin, Madison 5 participants Est. completion 2022-06-17 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT03356756

    PET MRI Study in Patients With Cardiac Sarcoidosis

    University Health Network, Toronto 40 participants Est. completion 2024-02-23 1 site
    Other conditions: Inflammatory Cardiomyopathy, Sarcoidosis
    View official trial listing →
  • Completed NCT NCT03370809

    Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry

    Not yet reported Central Hospital, Nancy, France 37 participants Est. completion 2022-08-10 1 site Stand-alone
    Other conditions: Patients Over 75 Years Old With a Cancer Discovery
    View official trial listing →
  • Completed NCT NCT03403127

    PET CT Re-Planning NSCLC (4DCT-PET)

    Not yet reported University Health Network, Toronto 36 participants Est. completion 2020-04-28
    Other conditions: Lung Cancer, Non-Small Cell Lung Cancer
    View official trial listing →
  • Terminated NCT NCT03423082

    Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.

    Not yet reported Nghi Nguyen 1 participants Est. completion 2019-12-18 1 site
    Other conditions: Cervical Cancer, Uterine Cancer
    View official trial listing →
  • Completed NCT NCT03429868

    PET and MRI in Prognosis Prediction of NPC

    Not yet reported Chang Gung Memorial Hospital 180 participants Est. completion 2020-07-31 1 site Stand-alone
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Status unknown NCT NCT03458585

    Radiation Exposure Awareness From Patients Undergoing Nuclear Medicine Diagnostic Scans

    Royal Marsden NHS Foundation Trust 100 participants Est. completion 2018-12-31 1 site
    Other conditions: Skeletal Scintigraphy, FDG PET/CT
    View official trial listing →
  • Completed NCT NCT03465098

    Evaluation of a Metabolic Preparation by a Low-carbohydrate Diet as Atkins-diet to Help in Detecting Infective Endocarditis by 18F-FDG PET

    Not yet reported Central Hospital, Nancy, France 26 participants Est. completion 2021-08-03 1 site Stand-alone
    Other conditions: Infective Endocarditis
    View official trial listing →
  • Completed NCT NCT03485170

    PET Imaging of Hemophilic Arthropathy

    Not yet reported Tri-Service General Hospital (TSGH) 20 participants Est. completion 2018-12-31 1 site
    Other conditions: Hemophilia, Arthropathy, Inflammation
    View official trial listing →
  • Terminated NCT NCT03513042

    Early Response Evaluation of Proton Therapy by PET-imaging in Squamous Cell Carcinoma Located in the Head and Neck

    Leiden University Medical Center 12 participants Est. completion 2022-11-23 1 site
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Status unknown NCT NCT03519659

    Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT

    Not yet reported University of Cincinnati 190 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: PET/CT Imaging
    View official trial listing →
  • Status unknown NCT NCT03582254

    Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years

    Not yet reported Assistance Publique - Hôpitaux de Paris 62 participants Est. completion 2023-05-12 1 site
    Other conditions: Primary Central Nervous System Lymphoma
    View official trial listing →
  • Completed NCT NCT03602911

    A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients

    Not yet reported West Virginia University 20 participants Est. completion 2021-04-01 1 site
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT03626571

    PET/MR Imaging In Patients With Infective Endocarditis

    University of Edinburgh 5 participants Est. completion 2024-10-28 1 site
    Other conditions: Infective Endocarditis
    View official trial listing →
  • Completed NCT NCT03683355

    Characterization of RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves.

    Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec 30 participants Est. completion 2025-03-01 1 site
    Other conditions: Infective Endocarditis
    View official trial listing →
  • Status unknown NCT NCT03695731

    Influence of Diabetic Neuropathy on Activation of Brown Adipose Tissue

    Not yet reported Doctor Giacomo Gastaldi 24 participants Est. completion 2019-10-15 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03695861

    Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves

    Not yet reported University Hospital, Bordeaux 31 participants Est. completion 2020-09-16 1 site Stand-alone
    Other conditions: Endocarditis
    View official trial listing →
  • Completed NCT NCT03705884

    PET/MR Imaging In Patients With Cardiac Sarcoidosis

    Not yet reported University of Edinburgh 40 participants Est. completion 2018-12-01 1 site
    Other conditions: Cardiac Sarcoidosis
    View official trial listing →
  • Terminated NCT NCT03712046

    Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis

    Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 2 participants Est. completion 2019-11-10 1 site Stand-alone
    Other conditions: Diabetic Foot Infection
    View official trial listing →
  • Status unknown NCT NCT03721055

    Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2019-12-31 1 site Stand-alone
    Other conditions: Cancer, Metastatic Cancer, Metastatic Brain Cancer
    View official trial listing →
  • Completed NCT NCT03726931

    FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET

    Not yet reported Amsterdam UMC, location VUmc 40 participants Est. completion 2023-01-29 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03732352

    18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma

    Not yet reported Jonsson Comprehensive Cancer Center 12 participants Est. completion 2024-01-31 1 site Stand-alone
    Other conditions: EGFR Gene Amplification, EGFR Gene Mutation, Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma, TP53 Wt Allele
    View official trial listing →
  • Status unknown NCT NCT03756077

    A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2023-12-31 1 site
    Other conditions: Prostate Cancer, PET/MR, PET/CT
    View official trial listing →
  • Completed NCT NCT03777839

    PET-FDG in Myocarditis

    Montreal Heart Institute 25 participants Est. completion 2024-08-31 1 site
    Other conditions: Myocarditis, Viral Myocarditis
    View official trial listing →
  • Completed NCT NCT03781284

    PET Combined With MRI for Monitoring Inflammatory Activity in Patients With Ulcerative Colitis

    Not yet reported Universität Duisburg-Essen 53 participants Est. completion 2018-10-31
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT03811015

    Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

    Not yet reported National Cancer Institute (NCI) 636 participants Est. completion 2030-01-31 727 sites
    Other conditions: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    View official trial listing →
  • Completed NCT NCT03824535

    18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

    Not yet reported Andrei Iagaru 15 participants Est. completion 2021-07-30 1 site Stand-alone
    Other conditions: Cigarette Smoker, Current Smoker, Former Smoker, Multiple Pulmonary Nodules, Pulmonary Nodule
    View official trial listing →
  • Status unknown NCT NCT03839706

    Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation

    Not yet reported University Health Network, Toronto 20 participants Est. completion 2024-09 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT03843515

    Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction

    Not yet reported Amsterdam UMC, location VUmc 17 participants Est. completion 2022-08-31 1 site
    Other conditions: Oral Cavity Squamous Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT03876912

    The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer

    Not yet reported Turku University Hospital 35 participants Est. completion 2023-03-01 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03891914

    Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma

    Not yet reported University Hospital, Bordeaux 20 participants Est. completion 2023-01-31 1 site Stand-alone
    Other conditions: Myeloma Multiple
    View official trial listing →
  • Terminated NCT NCT03923049

    Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis

    Not yet reported University of Alabama at Birmingham 5 participants Est. completion 2020-12-02 1 site
    Other conditions: Cardiac Sarcoidosis
    View official trial listing →
  • Status unknown NCT NCT03937583

    Screening for Cancer in Patients With Unprovoked VTE

    Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 650 participants Est. completion 2023-12-31 17 sites
    Other conditions: Venous Thromboembolic Disease, Respiratory Disease, Pulmonary Disease, Deep Venous Thrombosis, Pulmonary Embolism, Screening, Undefined
    View official trial listing →
  • Active, not recruiting NCT NCT03952585

    De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 384 participants Est. completion 2026-12-11 494 sites
    Other conditions: Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Oropharyngeal Squamous Cell Carcinoma, Papillary Squamous Cell Carcinoma, Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT03973164

    The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma

    Guangxi Medical University 142 participants Est. completion 2019-05-22 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04001023

    Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia

    Not yet reported Turku University Hospital 40 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma, Hypoxia
    View official trial listing →
  • Status unknown NCT NCT04001491

    Interest of 18F-FDG Positron Emission Tomography in the Management of Fevers and Inflammatory Syndromes

    University Hospital, Strasbourg, France 150 participants Est. completion 2020-08 1 site
    Other conditions: Inflammation
    View official trial listing →
  • Withdrawn NCT NCT04016818

    Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

    Not yet reported Stanford University Est. completion 2027-12 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04017104

    Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

    British Columbia Cancer Agency 60 participants Est. completion 2024-08-01 1 site
    Other conditions: Neuroendocrine Tumors, Prostate Cancer, Prostatic Neoplasms, Carcinoid Tumor, Paraganglioma, Neuroblastoma
    View official trial listing →
  • Completed NCT NCT04020978

    Parametric PET of Genitourinary Cancer

    Not yet reported University of California, Davis 11 participants Est. completion 2023-12-15 1 site
    Other conditions: Genitourinary Cancer
    View official trial listing →
  • Status unknown NCT NCT04036643

    Rectal Cancer Response Hybrid Imaging Assessement

    Not yet reported Assistance Publique - Hôpitaux de Paris 96 participants Est. completion 2023-02 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04045834

    Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60 participants Est. completion 2023-12-31 1 site
    Other conditions: PET / CT, PET / MR, Neuroendocrine Tumors, Osteomalacia
    View official trial listing →
  • Completed NCT NCT04080271

    Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.

    Assiut University 66 participants Est. completion 2021-12-01 1 site
    Other conditions: Bone Metastases
    View official trial listing →
  • Completed NCT NCT04110743

    EXPLORER PET/CT in Healthy Volunteers

    Not yet reported University of California, Davis 30 participants Est. completion 2020-02-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04117139

    The Diagnostic Value of PET/MRI in Head and Neck Cancer

    Not yet reported Odense University Hospital 142 participants Est. completion 2022-09-30 1 site
    Other conditions: Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymph Node Metastases
    View official trial listing →
  • Status unknown NCT NCT04127981

    Medical Imaging of Cachexia

    Not yet reported Olivia Newton-John Cancer Research Institute 40 participants Est. completion 2023-12-28 1 site
    Other conditions: Cancer Cachexia
    View official trial listing →
  • Withdrawn NCT NCT04140513

    Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center Est. completion 2023-11-01 1 site
    Other conditions: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Locally Advanced Oropharyngeal Squamous Cell Carcinoma, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
    View official trial listing →
  • Status unknown NCT NCT04154228

    Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI

    Not yet reported Tel-Aviv Sourasky Medical Center 100 participants Est. completion 2021-12-10 Stand-alone
    Other conditions: Lymphoma, Non Hodgkin Lymphoma, Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT04163276

    Database of Positon Emission Tomography (PET) Digital Brain Exams, in 50th Age of Patients

    Central Hospital, Nancy, France 80 participants Est. completion 2020-10 1 site
    Other conditions: Neurodegenerative Diseases
    View official trial listing →
  • Status unknown NCT NCT04196985

    18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC

    Not yet reported Turku University Hospital 40 participants Est. completion 2024-10-01 1 site
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT04219969

    FDG PET-MRI for the Diagnosis of Spinal Cord Lesions

    Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2024-05-07 1 site Stand-alone
    Other conditions: Spinal Cord Neoplasm
    View official trial listing →
  • Active, not recruiting NCT NCT04228172

    Genotypic Influences on Network Progression in Parkinson's Disease

    Northwell Health 32 participants Est. completion 2026-10-06 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT04233476

    99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer

    Not yet reported RDO Pharm. 409 participants Est. completion 2021-05-08 11 sites Stand-alone
    Other conditions: Lung Cancer, Lymph Node Metastasis
    View official trial listing →
  • Withdrawn NCT NCT04273555

    Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

    Not yet reported, Not yet reported University of Alabama at Birmingham Est. completion 2028-06-30 1 site
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT04276025

    Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma

    Klinikum Bayreuth GmbH 2000 participants Est. completion 2020-01
    Other conditions: NSCLC
    View official trial listing →
  • Completed NCT NCT04317313

    18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma

    Second Affiliated Hospital, Zhejiang University, School of Medicine 152 participants Est. completion 2021-07-30 1 site
    Other conditions: Lymphoma, Large B-Cell, Diffuse
    View official trial listing →
  • Active, not recruiting NCT NCT04327817

    Multifidus PET Scan Study

    Not yet reported Barts & The London NHS Trust 20 participants Est. completion 2027-03-17 1 site
    Other conditions: Low Back Pain
    View official trial listing →
  • Completed NCT NCT04356599

    Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Dynamic 18F-FDG PET/CT

    Not yet reported University Hospital, Montpellier 35 participants Est. completion 2024-02-19 1 site Stand-alone
    Other conditions: Aneurysmal Subarachnoid Haemorrhage
    View official trial listing →
  • Completed NCT NCT04411966

    Early Interim 18F-FDG-PET and 18F-FLT-PET for Predicting Treatment Response and Survival in Metastatic Breast Cancer

    Not yet reported Chang Gung Memorial Hospital 32 participants Est. completion 2019-05-30
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04412369

    Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury

    University of Cambridge 21 participants Est. completion 2023-08-01 1 site
    Cardiovascular disease Other conditions: COVID19
    View official trial listing →
  • Completed NCT NCT04417998

    Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction

    Not yet reported Mayo Clinic 80 participants Est. completion 2023-12-20 1 site
    Other conditions: Brain Imaging, Whole Body Imaging
    View official trial listing →
  • Completed NCT NCT04437927

    Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT

    Centre Hospitalier Princesse Grace 51 participants Est. completion 2020-11-06 1 site
    Other conditions: Metabolic Preparation, Myocardial Inflammation
    View official trial listing →
  • Completed NCT NCT04464590

    Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT

    University Hospital, Brest 100 participants Est. completion 2018-12-31
    Other conditions: Malignant Lymphoma, Relapsed Non Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Diagnostic Imaging
    View official trial listing →
  • Status unknown NCT NCT04467580

    Development of Inflammation and Fibrosis Index, Combining MRI and PET 18F-FDG, in Patient's With Crohn's Disease

    Not yet reported Central Hospital, Nancy, France 59 participants Est. completion 2023-05-02
    Other conditions: Crohn Disease
    View official trial listing →
  • Status unknown NCT NCT04470076

    Neoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating Mutation

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 30 participants Est. completion 2023-07-30 Stand-alone
    Other conditions: Non Small Cell Lung Cancer, Surgery, EGFR Activating Mutation, Chemotherapy, EGFR TKI
    View official trial listing →
  • Status unknown NCT NCT04502303

    18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease

    Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2021-09 Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Status unknown NCT NCT04504110

    68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings

    Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2021-08 1 site Stand-alone
    Other conditions: Epithelial Ovarian Cancer
    View official trial listing →
  • Status unknown NCT NCT04514822

    Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCC

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 40 participants Est. completion 2023-12-30 1 site
    Other conditions: Esophageal Squamous Cell Carcinoma, Positron Emission Tomography
    View official trial listing →
  • Status unknown NCT NCT04519255

    Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT

    Fifth Affiliated Hospital, Sun Yat-Sen University 60 participants Est. completion 2023-07-31 1 site
    Other conditions: PET/CT, COVID-19, Respiratory Function, Inflammatory Lesions
    View official trial listing →
  • Completed NCT NCT04566185

    Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma

    Not yet reported Centre Hospitalier Universitaire de Nīmes 14 participants Est. completion 2023-06-27 1 site
    Other conditions: Glioblastoma
    View official trial listing →
  • Completed NCT NCT04588064

    18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

    Not yet reported The First Affiliated Hospital of Xiamen University 63 participants Est. completion 2022-07-01 1 site Stand-alone
    Other conditions: Lung Adenocarcinoma, 18F-FDG, 68Ga-FAPI, PET/CT
    View official trial listing →
  • Completed NCT NCT04599634

    Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies

    Not yet reported National Cancer Institute (NCI) 11 participants Est. completion 2024-06-20 1 site
    Other conditions: Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Lymphoma, B-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04622631

    Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT

    Dr. Nayruz Knaana 80 participants Est. completion 2023-01 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT04756921

    18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response

    Biyun Wang, MD 30 participants Est. completion 2020-07-24 1 site
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT04764721

    Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19

    Not yet reported Central Hospital, Nancy, France 25 participants Est. completion 2023-11-27 1 site Stand-alone
    Other conditions: Covid-19
    View official trial listing →
  • Active, not recruiting NCT NCT04804371

    Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

    Not yet reported University Health Network, Toronto 40 participants Est. completion 2027-02-22 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT04812080

    EXPLORER PET/CT: Evaluation of Healthy Individuals From Racial/Ethnic Minority Populations

    Not yet reported University of California, Davis 20 participants Est. completion 2021-11-08 1 site Stand-alone
    Other conditions: Healthy Volunteers From Racial/Ethnic Minority Populations
    View official trial listing →
  • Completed NCT NCT04841707

    Total-Body Parametric 18F-FDG PET of COVID-19

    Not yet reported University of California, Davis 13 participants Est. completion 2022-07-06 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04851379

    PLACE OF THE 18F-FDG-PET/CT IN THE DIAGNOSTIC WORKUP IN PATIENTS WITH CLASSICAL FEVER OF UNKNOWN ORIGIN (FUO)

    University Hospital, Montpellier 44 participants Est. completion 2021-04-01 1 site
    Other conditions: Fever of Unknown Origin
    View official trial listing →
  • Active, not recruiting NCT NCT04892667

    Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG

    Not yet reported Assistance Publique - Hôpitaux de Paris 128 participants Est. completion 2026-03-17 1 site
    Other conditions: Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin
    View official trial listing →
  • Status unknown NCT NCT04931875

    Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma

    RenJi Hospital 100 participants Est. completion 2024-07-20 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT04943211

    Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging

    Not yet reported Anna Raciborska 150 participants Est. completion 2027-06-30 1 site
    Other conditions: Histiocytosis
    View official trial listing →
  • Status unknown NCT NCT04996927

    18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50 participants Est. completion 2023-06-01 1 site
    Other conditions: NSCLC
    View official trial listing →
  • Status unknown NCT NCT05003830

    Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 130 participants Est. completion 2023-09-01 1 site
    Other conditions: Alzheimer Disease, PET/MR
    View official trial listing →
  • Terminated NCT NCT05009979

    18F-DCFPyL PET/CT in Hepatocellular Carcinoma

    Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2024-11-20 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05030597

    Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma

    Zhongnan Hospital 100 participants Est. completion 2025-12-31 1 site
    Other conditions: PET/CT, FAPI, Oral Cancer
    View official trial listing →
  • Completed NCT NCT05054998

    Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases

    Not yet reported M.D. Anderson Cancer Center 12 participants Est. completion 2024-04-26 1 site
    Other conditions: Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm
    View official trial listing →
  • Enrolling by invitation NCT NCT05108857

    PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9

    Turku University Hospital 10 participants Est. completion 2026-12-31 1 site
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Status unknown NCT NCT05111197

    Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy

    Not yet reported Institut Cancerologie de l'Ouest 112 participants Est. completion 2025-01 5 sites
    Other conditions: Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT05113576

    Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL

    Second Affiliated Hospital, Zhejiang University, School of Medicine 132 participants Est. completion 2021-06-30 1 site
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT05141643

    Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 30 participants Est. completion 2026-11-18 1 site
    Other conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05165602

    Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System

    Peking University 30 participants Est. completion 2023-05-01 1 site
    Other conditions: HER2 Positive Gastric Cancer
    View official trial listing →
  • Completed NCT NCT05174026

    18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery

    Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2024-06-20 1 site Stand-alone
    Other conditions: Metastatic Malignant Neoplasm, Metastatic Malignant Neoplasm in the Bone
    View official trial listing →
  • Completed NCT NCT05183555

    Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis

    Not yet reported Central Hospital, Nancy, France 14 participants Est. completion 2024-06-18 1 site Stand-alone
    Other conditions: Infective Endocarditis
    View official trial listing →
  • Active, not recruiting NCT NCT05211336

    Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System

    Not yet reported National Cancer Institute (NCI) 14 participants Est. completion 2029-06-01 1 site Stand-alone
    Other conditions: Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
    View official trial listing →
  • Completed NCT NCT05248906

    Giant Cell Arteritis - Optimization of Diagnostics

    Copenhagen University Hospital, Rigshospitalet 110 participants Est. completion 2024-01-01 1 site
    Other conditions: Giant Cell Arteritis
    View official trial listing →
  • Active, not recruiting NCT NCT05255159

    Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors

    Not yet reported University of Alberta 50 participants Est. completion 2026-12-31 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT05286801

    Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

    Not yet reported, Not yet reported National Cancer Institute (NCI) 86 participants Est. completion 2030-03-31 40 sites
    Other conditions: Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma, Malignant Solid Neoplasm, Poorly Differentiated Chordoma, Recurrent Atypical Teratoid/Rhabdoid Tumor, Recurrent Chordoma, Recurrent Epithelioid Sarcoma, Recurrent Kidney Medullary Carcinoma, Recurrent Malignant Solid Neoplasm, Recurrent Rhabdoid Tumor, Refractory Atypical Teratoid/Rhabdoid Tumor, Refractory Chordoma, Refractory Epithelioid Sarcoma, Refractory Kidney Medullary Carcinoma, Refractory Malignant Solid Neoplasm, Refractory Rhabdoid Tumor, Rhabdoid Tumor
    View official trial listing →
  • Status unknown NCT NCT05339113

    Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma

    Not yet reported The National Center of Oncology, Azerbaijan 100 participants Est. completion 2022-12 1 site
    Other conditions: Breast Neoplasms, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor, Fluorodeoxyglucose F18
    View official trial listing →
  • Withdrawn NCT NCT05390021

    PET/MRI in Endometrial Cancer

    Not yet reported Massachusetts General Hospital Est. completion 2026-02-01
    Other conditions: Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma, Endometrial Undifferentiated Carcinoma, Endometrial Mixed Cell Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05390632

    Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas

    Peking University Cancer Hospital & Institute 100 participants Est. completion 2023-12-15 1 site
    Other conditions: PET/MRI
    View official trial listing →
  • Status unknown NCT NCT05396118

    Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

    Not yet reported Copenhagen University Hospital, Rigshospitalet 15 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Carcinoma Metastatic, Lymphoma, Sarcoma
    View official trial listing →
  • Status unknown NCT NCT05418907

    Exendin PET/CT for Imaging of Paragangliomas

    Radboud University Medical Center 10 participants Est. completion 2024-12-01 1 site
    Other conditions: Paraganglioma
    View official trial listing →
  • Completed NCT NCT05430841

    Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

    Not yet reported The First Affiliated Hospital of Xiamen University 120 participants Est. completion 2024-10-31 1 site Stand-alone
    Other conditions: Gastric Cancer, Pancreatic Cancer, Liver Cancer
    View official trial listing →
  • Completed NCT NCT05432427

    64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis.

    Not yet reported Emil Loldrup Fosbol 69 participants Est. completion 2023-09-29 1 site Stand-alone
    Other conditions: Endocarditis, Endocarditis;Chronic, Endocarditis Acute
    View official trial listing →
  • Completed NCT NCT05432947

    68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

    Not yet reported Peking Union Medical College Hospital 42 participants Est. completion 2022-09-15 1 site Stand-alone
    Other conditions: Clear Cell Renal Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05448404

    A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma

    Not yet reported First Hospital of China Medical University 30 participants Est. completion 2023-06-30 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT05455047

    Study of Metabolic Connectivity in Drug-resistant Temporal Epilepsy

    Central Hospital, Nancy, France 90 participants Est. completion 2022-06-01 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT05458089

    18F-FDG PET/CT in the Diagnosis of Tuberculous Pericarditis

    Wuxi No. 4 People's Hospital 11 participants Est. completion 2022-02-28
    Other conditions: Diagnostic Self Evaluation
    View official trial listing →
  • Status unknown NCT NCT05490849

    68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Status unknown NCT NCT05496101

    CLI and FAR for Intraoperative Margin Assessment

    Not yet reported King's College London 60 participants Est. completion 2024-12-31 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT05506566

    68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies

    Not yet reported, Not yet reported First Affiliated Hospital of Fujian Medical University 50 participants Est. completion 2025-05-01 1 site Stand-alone
    Other conditions: Tumor, Positron-Emission Tomography
    View official trial listing →
  • Status unknown NCT NCT05577299

    Factors Affecting BAT Activation in PET/CT

    Assiut University 80 participants Est. completion 2025-10-01
    Other conditions: Factors Affecting BAT Activation in PET/CT
    View official trial listing →
  • Status unknown NCT NCT05615103

    The PET-CT Predicting Response to Immunochemotherapy in Esophageal Cancer

    Guangdong Provincial People's Hospital 100 participants Est. completion 2023-12-08 1 site
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT05617742

    Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

    Not yet reported Chang Gung Memorial Hospital 58 participants Est. completion 2026-01-31 1 site Stand-alone
    Other conditions: Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT05622227

    68Ga PET/CT Imaging in Breast Cancer Patients

    Not yet reported, Not yet reported Peking Union Medical College Hospital 50 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05645484

    The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2023-08-31 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Status unknown NCT NCT05687552

    Role of 18F-FDG PET/CT in Gastric Cancer

    Sohag University 50 participants Est. completion 2024-01
    Other conditions: Gastric Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05710328

    Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

    Not yet reported ECOG-ACRIN Cancer Research Group 235 participants Est. completion 2029-12-31 102 sites
    Other conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05788874

    Study of 18F-FAPI Applied to Gastrointestinal Cancer

    First Affiliated Hospital Xi'an Jiaotong University 50 participants Est. completion 2024-12
    Other conditions: Gastrointestinal Cancer
    View official trial listing →
  • Status unknown NCT NCT05803629

    Characterizing Histiocytosis With 68Ga-FAPI PET/CT

    Not yet reported Peking Union Medical College Hospital 100 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Histiocytosis
    View official trial listing →
  • Status unknown NCT NCT05803746

    PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor

    Not yet reported Peking University Cancer Hospital & Institute 20 participants Est. completion 2024-07-15 1 site Stand-alone
    Other conditions: Lung Cancer, Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT05819905

    Radiomics for prEdiction of lunG cAncer biologY

    Poitiers University Hospital 600 participants Est. completion 2024-01-01 1 site
    Other conditions: Non Small Cell Lung Cancer, PET/CT, PD-L1, Gene Mutation-Related Cancer
    View official trial listing →
  • Status unknown NCT NCT05831371

    Discard the Curative Causes of Late Onset Epilepsy: the Role of Brain 18F-FDG PET

    Central Hospital, Nancy, France 87 participants Est. completion 2023-09-02 1 site
    Other conditions: Late Onset Epilepsy, Alzheimer Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05844306

    RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

    Not yet reported City of Hope Medical Center 20 participants Est. completion 2027-08-17 1 site
    Other conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
    View official trial listing →
  • Completed NCT NCT05855291

    PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer Patients

    Not yet reported Chang Gung Memorial Hospital 43 participants Est. completion 2021-07-31 1 site Stand-alone
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Status unknown NCT NCT05879471

    68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

    Not yet reported Peking Union Medical College Hospital 39 participants Est. completion 2025-07-01 1 site
    Other conditions: Metastatic Clear Cell Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT05885854

    XTR003 PET Radiotracer for the Detection of Viable Myocardium

    Not yet reported Sinotau Pharmaceutical Group 51 participants Est. completion 2023-03-05 1 site Stand-alone
    Other conditions: Ischemic Heart Disease (IHD)
    View official trial listing →
  • Status unknown NCT NCT05912465

    Predicting Lung Cancer-Associated Cachexia With PET Imaging

    Not yet reported Medical University of Vienna 150 participants Est. completion 2025-03-01 3 sites
    Other conditions: Cachexia, Lung Neoplasm
    View official trial listing →
  • Status unknown NCT NCT05919199

    PET Tracer Based FDG Signal for Predicting Prognosis in Acute Myeloid Leukemia

    First Affiliated Hospital of Jinan University 60 participants Est. completion 2024-12 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT05936411

    Organ Interaction Patterns in Healthy Individuals for Improved PET/CT Diagnostics

    Not yet reported Medical University of Vienna 50 participants Est. completion 2026-01-01
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05937776

    Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

    OHSU Knight Cancer Institute 4 participants Est. completion 2025-12-31 1 site
    Other conditions: Glioma
    View official trial listing →
  • Withdrawn NCT NCT05950113

    CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma

    Not yet reported Jonsson Comprehensive Cancer Center Est. completion 2028-03-28 1 site
    Other conditions: Recurrent Multiple Myeloma, Refractory Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT05963035

    Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Clear Cell Sarcoma of Soft Tissue
    View official trial listing →
  • Completed NCT NCT05994768

    18F-FDG Tomography and Labeled Leukocyte Scintigraphy

    Central Hospital, Nancy, France 18 participants Est. completion 2023-10-18 1 site
    Other conditions: Malignant Otitis Externa
    View official trial listing →
  • Status unknown NCT NCT06010290

    The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism Patients

    Anhui Provincial Hospital 80 participants Est. completion 2023-12-31 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Not yet recruiting NCT NCT06055764

    Role of FDG PET/CT in Patients With Metastasis of Unknown Origin

    Assiut University 73 participants Est. completion 2026-12
    Other conditions: Metastasis
    View official trial listing →
  • Status unknown NCT NCT06126705

    18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor

    Not yet reported Affiliated Hospital of North Sichuan Medical College 60 participants Est. completion 2024-07 1 site Stand-alone
    Other conditions: Tumor, Solid
    View official trial listing →
  • Withdrawn NCT NCT06145399

    A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2024-04-29 Stand-alone
    Other conditions: Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer, Metastatic Breast Carcinoma, Female Breast Cancer
    View official trial listing →
  • Completed NCT NCT06151054

    Relationship Between Aortic Parietal Inflammation on 18F-FDG PET Scan and Arterial Stiffness as a Function of Age

    Central Hospital, Nancy, France 89 participants Est. completion 2022-12-06 1 site
    Other conditions: Arterial Stiffness
    View official trial listing →
  • Status unknown NCT NCT06159920

    Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.

    IRCCS San Raffaele 800 participants Est. completion 2024-12-27 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Not yet recruiting NCT NCT06162988

    PET Imaging of 68Ga-NOTA-H006 in Malignancy

    Not yet reported YiHui Guan 15 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Tumor, Solid
    View official trial listing →
  • Completed NCT NCT06168877

    Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.

    IRCCS San Raffaele 30 participants Est. completion 2014-07-03
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT06170151

    Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma

    IRCCS San Raffaele 10 participants Est. completion 2022-12-01 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT06182644

    Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors

    Not yet reported Guangdong Provincial People's Hospital 30 participants Est. completion 2025-09-01 1 site
    Other conditions: Renal Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma, Signet Ring Cell Carcinoma, Mucinous Adenocarcinoma, Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT06188468

    ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors

    Not yet reported The First Affiliated Hospital of Xiamen University 90 participants Est. completion 2024-08-31 1 site Stand-alone
    Other conditions: Tumor, Solid Tumor, Positron-Emission Tomography
    View official trial listing →
  • Completed NCT NCT06203119

    Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe

    Not yet reported Peking University Cancer Hospital & Institute 18 participants Est. completion 2025-12-18 1 site Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06209567

    A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 11 participants Est. completion 2027-01-05 7 sites Stand-alone
    Other conditions: High-grade Glioma, Brain Metastases, Brain Metastases, Adult
    View official trial listing →
  • Completed NCT NCT06211803

    Clinical Application of the Prototype J-PET Device

    Jagiellonian University 10 participants Est. completion 2022-03-22 1 site
    Other conditions: Neurodegenerative Diseases, Brain Neoplasms, Neuroendocrine Tumors
    View official trial listing →
  • Status unknown NCT NCT06304155

    Application of FDG Combined With FAPI PET Dual Imaging in the Diagnosis and Staging of Oropharyngeal and Laryngeal Cancer

    Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 40 participants Est. completion 2026-01-01 1 site
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT06317142

    Glucose and Glycogen Dynamics in Prediabetes

    Maastricht University Medical Center 45 participants Est. completion 2025-07 1 site
    Other conditions: Pre Diabetes
    View official trial listing →
  • Status unknown NCT NCT06327386

    The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer

    Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 32 participants Est. completion 2026-01-01 1 site
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT06344845

    Clinical Study of [18F] PM-PBB3 PET Imaging of Tau Protein in Neurodegenerative Diseases

    Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2025-11 1 site Stand-alone
    Other conditions: Neurodegenerative Diseases
    View official trial listing →
  • Completed NCT NCT06359054

    The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging

    Not yet reported Manisa Celal Bayar University 16 participants Est. completion 2023-09-15 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT06379295

    Coronary Artery Calcification Assessed on PET Scanner (PET : Positron Emission Tomography)

    Centre Hospitalier Régional d'Orléans 200 participants Est. completion 2024-07-22 1 site
    Cardiovascular disease Other conditions: Coronary Artery Calcification
    View official trial listing →
  • Completed NCT NCT06383598

    PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors

    Not yet reported Hua Zhu 50 participants Est. completion 2026-09-24 1 site Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Not yet recruiting NCT NCT06452290

    PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder

    Not yet reported Central Hospital, Nancy, France 30 participants Est. completion 2029-03-01 Stand-alone
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Status unknown NCT NCT06455735

    68Ga-JH04 PET/CT in Patients With Various Types of Cancer

    Not yet reported First Affiliated Hospital of Fujian Medical University 30 participants Est. completion 2026-04-01 1 site Stand-alone
    Other conditions: Tumor
    View official trial listing →
  • Status unknown NCT NCT06455761

    68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of Cancer

    Not yet reported First Affiliated Hospital of Fujian Medical University 30 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Tumor
    View official trial listing →
  • Completed NCT NCT06460454

    PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing

    Central Hospital, Nancy, France 100 participants Est. completion 2025-02-25 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT06465017

    ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

    Not yet reported The First Affiliated Hospital of Xiamen University 149 participants Est. completion 2026-01-31 1 site Stand-alone
    Other conditions: Tumor, Solid Tumor, Thyroid Cancer, Positron-Emission Tomography
    View official trial listing →
  • Status unknown NCT NCT06494800

    Added Value of PET/CT in Lung Cancer

    Sohag University 30 participants Est. completion 2025-12-01
    Other conditions: Lung Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06511323

    Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PET

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 70 participants Est. completion 2027-08
    Other conditions: Brain Metastases
    View official trial listing →
  • Status unknown NCT NCT06519240

    A Pilot Study Evaluating the Potential of 18F Fluorodeoxyglucose PET-CT Imaging in Diagnosing Cardiac Rejection.

    Not yet reported Royal Brompton & Harefield NHS Foundation Trust 20 participants Est. completion 2026-10-02
    Other conditions: Cardiac Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT06531343

    Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and Characterization

    Not yet reported IRCCS San Raffaele 334 participants Est. completion 2026-08-30 1 site
    Other conditions: Lung Cancer Screening
    View official trial listing →
  • Active, not recruiting NCT NCT06557148

    A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

    Memorial Sloan Kettering Cancer Center 7 participants Est. completion 2027-08-13 7 sites
    Other conditions: Breast Cancer, Lobular Breast Carcinoma, Breast Carcinoma, Metastatic Breast Cancer, Metastatic Lobular Breast Carcinoma, Metastatic Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06584747

    Study of Cerebral Vascular Reserve Using Pharmacological Testing With Acetazolamide: A Non-Inferiority Study of PET Method Compared to Conventional Reference Scintigraphy

    Not yet reported Centre Antoine Lacassagne 19 participants Est. completion 2027-04-09 1 site Stand-alone
    Other conditions: Cerebrovascular Circulation
    View official trial listing →
  • Not yet recruiting NCT NCT06626932

    Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions

    mahenoor alaa eldeen naem 259 participants Est. completion 2026-11 1 site
    Other conditions: Oncologic Diseases
    View official trial listing →
  • Active, not recruiting NCT NCT06630845

    Comparison of Whole Body DWI to FDG PET

    Not yet reported University of California, San Francisco 25 participants Est. completion 2029-04-30 1 site
    Other conditions: Metastatic Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06700564

    The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies

    Shanghai East Hospital 60 participants Est. completion 2027-11-30
    Other conditions: Hepatoma
    View official trial listing →
  • Completed NCT NCT06721130

    Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot Study

    Post Graduate Institute of Medical Education and Research, Chandigarh 54 participants Est. completion 2024-06-30 1 site
    Other conditions: Cavernous Sinus Syndrome, Cavernous Sinus Meningioma, Cavernous Sinus Lesions
    View official trial listing →
  • Not yet recruiting NCT NCT06726512

    Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy

    Not yet reported University Medical Center Groningen 30 participants Est. completion 2026-04 1 site
    Obstructive sleep apnea Other conditions: Oral Cancer, Soft Tissue Sarcoma, Oral Squamous Cell Carcinoma (OSCC)
    View official trial listing →
  • Not yet recruiting NCT NCT06747299

    The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study

    Ruijin Hospital 200 participants Est. completion 2027-12-31 1 site
    Other conditions: T-NK Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06755086

    TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors

    Peking University Cancer Hospital & Institute 20 participants Est. completion 2026-12-31 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Enrolling by invitation NCT NCT06829043

    18F-FDG PET/TC in TIR3A e TIR3B

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 216 participants Est. completion 2027-02-01 1 site
    Other conditions: PET / CT, FDG PET/CT, Cytology, Thyroid Nodules
    View official trial listing →
  • Status unknown NCT NCT06834412

    A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging

    Not yet reported Xijing Hospital 120 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Active, not recruiting NCT NCT06877208

    The Effect of Glucagon on Cerebral Glucose Metabolism in Healthy Humans

    Not yet reported Nicolai Jacob Wewer Albrechtsen 12 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Cerebral Glucose Metabolism
    View official trial listing →
  • Not yet recruiting NCT NCT06916442

    Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy

    Zhongnan Hospital 200 participants Est. completion 2027-12-31 1 site
    Other conditions: PET/CT, Solid Tumors, Adult, Solid Tumors, Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT06919159

    Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

    Jiequn Yu 45 participants Est. completion 2022-11-30 1 site
    Other conditions: Prostate Cancer (Diagnosis), Prostate-specific Membrane Antigen, Positron Emission Tomography (PET)
    View official trial listing →
  • Not yet recruiting NCT NCT06947759

    Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma

    Taichung Veterans General Hospital 20 participants Est. completion 2026-04-30 1 site
    Other conditions: Nuclear Medicine, Oncology
    View official trial listing →
  • Completed NCT NCT06982053

    [68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 21 participants Est. completion 2025-03-31 1 site
    Other conditions: Colorectal Cancer Control and Prevention, Colorectal Cancer Recurrent, Colorectal Cancer Metastatic, Colorectal Cancer Screening
    View official trial listing →
  • Completed NCT NCT06995976

    Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

    Not yet reported First Affiliated Hospital of Fujian Medical University 15 participants Est. completion 2026-03-01 1 site Stand-alone
    Other conditions: Malignant Tumour
    View official trial listing →
  • Not yet recruiting NCT NCT07022080

    Evaluating the Effectiveness of 68Ga-grazytracer PET/CT in Inflammatory Bowel Disease

    Not yet reported Xijing Hospital 69 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Inflammatory Bowel Diseases (IBD)
    View official trial listing →
  • Enrolling by invitation NCT NCT07023848

    PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

    Not yet reported Affiliated Hospital of Jiangnan University 10 participants Est. completion 2026-12-01 1 site Stand-alone
    Other conditions: Breast Cancer, Gastric Cancer (GC), Urothelial Carcinoma (UC)
    View official trial listing →
  • Not yet recruiting NCT NCT07029295

    Evaluation of the Impact of a Patient Education Protocol on the Quality of 18F-FDG PET Imaging Indicated for Investigation of Cardiac Inflammation

    Not yet reported Assistance Publique - Hôpitaux de Paris 138 participants Est. completion 2027-08-31 2 sites
    Other conditions: Infective Endocarditis, Cardiac Sarcoidosis
    View official trial listing →
  • Active, not recruiting NCT NCT07118176

    Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

    Not yet reported Jonsson Comprehensive Cancer Center 30 participants Est. completion 2027-09-07 1 site Stand-alone
    Other conditions: Anal Carcinoma, Bladder Carcinoma, Breast Carcinoma, Cervical Carcinoma, Cholangiocarcinoma, Colorectal Carcinoma, Esophageal Carcinoma, Gastric Carcinoma, Head and Neck Carcinoma, Hematopoietic and Lymphatic System Neoplasm, Hepatocellular Carcinoma, Lung Carcinoma, Malignant Adrenal Gland Neoplasm, Malignant Brain Neoplasm, Malignant Neoplasm of Unknown Primary, Malignant Solid Neoplasm, Malignant Testicular Neoplasm, Malignant Uterine Neoplasm, Neuroendocrine Neoplasm, Ovarian Carcinoma, Pancreatic Carcinoma, Penile Carcinoma, Pleural Carcinomatosis, Primary Peritoneal Carcinoma, Prostate Carcinoma, Salivary Gland Carcinoma, Sarcoma, Skin Carcinoma, Solitary Fibrous Tumor, Thymus Carcinoma, Thyroid Gland Carcinoma, Thyroid Gland Medullary Carcinoma, Urothelial Carcinoma, Vaginal Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07127627

    Characterization of Abdomino-pelvic Lesions by 18Fluorine- Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

    Assiut University 79 participants Est. completion 2028-11
    Other conditions: Abdominal Sepsis
    View official trial listing →
  • Not yet recruiting NCT NCT07163806

    Volumetric Parameter of 18F-FDG PET/CT in Characterizing Thyroid Incidentalomas

    Fatma Abelzaher Mahmoud Ahmed 88 participants Est. completion 2028-05-30
    Other conditions: Thyroid Incidentalomas
    View official trial listing →
  • Not yet recruiting NCT NCT07172503

    Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 56 participants Est. completion 2026-12-31 1 site
    Other conditions: Colorectal Cancer, Gastric Cancer (GC), Pancreatic Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07285993

    Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

    Not yet reported Randy Yeh 15 participants Est. completion 2027-12-30 1 site Stand-alone
    Other conditions: Breast Cancer, Metastatic Invasive Lobular Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07306975

    Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.

    Assiut University 80 participants Est. completion 2027-12-01
    Other conditions: Cancer Patients Referred to do PET/CT Study
    View official trial listing →
  • Not yet recruiting NCT NCT07353554

    Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma

    Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2028-02-01 1 site Stand-alone
    Other conditions: Multiple Myeloma (MM)
    View official trial listing →
  • Active, not recruiting NCT NCT07366710

    Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET

    Not yet reported Copenhagen University Hospital, Rigshospitalet 36 participants Est. completion 2027-10 1 site Stand-alone
    MASLD Other conditions: Glucose Metabolism
    View official trial listing →
  • Not yet recruiting NCT NCT07370805

    18F-FAPI PET in Lung Cancer

    First Affiliated Hospital of Zhejiang University 120 participants Est. completion 2028-12-31 1 site
    Other conditions: Lung Cancer (Diagnosis)
    View official trial listing →
  • Not yet recruiting NCT NCT07419867

    A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI

    Not yet reported Fudan University 300 participants Est. completion 2032-01-01 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT07430475

    Utility of 18F-FDG PET/CT for Suspected Infection in the Inpatient Setting: a Single Centre Retrospective Cohort Study

    University of Adelaide 266 participants Est. completion 2024-01-29 1 site
    Other conditions: Fever of Unknown Origin, Inflammation of Unknown Origin, Fever, Inflammation
    View official trial listing →
  • Not yet recruiting NCT NCT07431255

    Generation of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's Disease

    IRCCS San Raffaele 35 participants Est. completion 2026-12-31 1 site
    Other conditions: Alzheimer Disease (AD)
    View official trial listing →
  • Active, not recruiting NCT NCT07449858

    18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC

    Second Affiliated Hospital, Zhejiang University, School of Medicine 500 participants Est. completion 2027-12-31 4 sites
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT07506447

    The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 68 participants Est. completion 2026-03-13 1 site
    Obstructive sleep apnea Other conditions: FDG PET
    View official trial listing →
  • Completed NCT NCT07528131

    18F-FDG PET/CT in Gastric Cancer

    Sohag University 50 participants Est. completion 2024-09-22 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07536321

    Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in the Follow up of Patients With Colorectal Carcinoma.

    Assiut University 46 participants Est. completion 2031-03-05
    Other conditions: Rectal Cancer (Stage III)
    View official trial listing →
  • Completed NCT NCT07553741

    Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27 participants Est. completion 2026-04-01 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07646873

    PET-Enabled Dual-Energy CT in Multiple Myeloma

    Not yet reported University of California, Davis 45 participants Est. completion 2030-11 1 site Stand-alone
    Other conditions: Multiple Myeloma (MM)
    View official trial listing →
  • Not yet recruiting NCT NCT07708103

    Clinical Evaluation of [68Ga]Ga-FFD PET Imaging in Healthy Volunteers and Patients With Solid Tumors

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12 participants Est. completion 2027-07-30 1 site Stand-alone
    Other conditions: Solid Tumor Malignancies
    View official trial listing →
  • Completed NCT NCT07712172

    Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3

    Post Graduate Institute of Medical Education and Research, Chandigarh 31 participants Est. completion 2026-05-30 1 site
    Other conditions: Granulomatosis With Polyangiitis (Wegener's)
    View official trial listing →
  • Not yet recruiting NCT NCT07727317

    Evaluate the Diagnostic Efficacy and Safety of INR 202 PET/CT Imaging in Participants With Advanced Solid Tumors

    Not yet reported Shanghai Zhongshan Hospital 30 participants Est. completion 2028-07 Stand-alone
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT07825467

    Brown Adipose Tissue Activity and NAFLD Progression

    Renmin Hospital of Wuhan University 96 participants Est. completion 2026-02-05 1 site
    MASLD
    View official trial listing →
  • Not yet recruiting NCT NCT07828691

    18F-FDG PET/CT for Diagnosis of Diabetic Foot Osteomyelitis

    Jewish General Hospital 150 participants Est. completion 2029-04 4 sites
    Other conditions: Diabetic Foot Infections
    View official trial listing →
  • Not yet recruiting NCT NCT07867925

    Predicting Endocrine Resistance Using Molecular Imaging and Liquid Biopsy in Metastatic Breast Cancer

    Asan Medical Center 100 participants Est. completion 2030-12-31 1 site
    Other conditions: Metastatic Breast Cancer (HR+/ HER2-)
    View official trial listing →
  • Not yet recruiting NCT NCT07875946

    68Ga- and 18F-CAIX PET Imaging Study

    Not yet reported Peking University First Hospital 100 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Renal Tumor
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.